Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2023 | May 05, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-36094 | |
Entity Registrant Name | THE COMMUNITY FINANCIAL CORPORATION | |
Entity Incorporation, State or Country Code | MD | |
Entity Tax Identification Number | 52-1652138 | |
Entity Address, Address Line One | 3035 Leonardtown Road | |
Entity Address, City or Town | Waldorf | |
Entity Address, State or Province | MD | |
Entity Address, Postal Zip Code | 20601 | |
City Area Code | (301) | |
Local Phone Number | 645-5601 | |
Title of 12(b) Security | Common Stock, par value $0.01 per share | |
Trading Symbol | TCFC | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 5,669,274 | |
Current Fiscal Year End Date | --12-31 | |
Entity Central Index Key | 0000855874 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2023 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Assets | ||
Cash and due from banks | $ 11,905 | $ 11,511 |
Federal funds sold | 2,290 | 2,140 |
Interest-bearing deposits with banks | 13,297 | 11,822 |
Securities available for sale ("AFS"), at fair value | 463,949 | 462,746 |
Equity securities carried at fair value through income | 4,380 | 4,286 |
Non-marketable equity securities held in other financial institutions | 207 | 207 |
Federal Home Loan Bank ("FHLB") stock - at cost | 2,181 | 4,584 |
Net loans | 1,820,806 | 1,798,517 |
Goodwill | 10,835 | 10,835 |
Premises and equipment, net | 20,987 | 21,308 |
Accrued interest receivable | 8,526 | 8,335 |
Investment in bank owned life insurance | 40,019 | 39,802 |
Core deposit intangible | 550 | 634 |
Net deferred tax assets | 21,914 | 24,657 |
Right of use assets - operating leases | 5,817 | 5,920 |
Other assets | 873 | 2,713 |
Total Assets | 2,428,536 | 2,410,017 |
Deposits | ||
Non-interest-bearing deposits | 599,763 | 630,120 |
Interest-bearing deposits | 1,554,560 | 1,458,343 |
Total deposits | 2,154,323 | 2,088,463 |
Short-term borrowings | 21,500 | 79,000 |
Guaranteed preferred beneficial interest in junior subordinated debentures ("TRUPs") | 12,000 | 12,000 |
Subordinated notes net of debt issuance costs - 4.75% | 19,580 | 19,566 |
Lease liabilities - operating leases | 6,114 | 6,202 |
Accrued expenses and other liabilities | 16,213 | 17,775 |
Total Liabilities | 2,229,730 | 2,223,006 |
Stockholders’ Equity | ||
Common stock - par value $0.01; authorized - 15,000,000 shares; issued 5,666,904 and 5,648,435 shares, respectively | 57 | 56 |
Additional paid in capital | 98,246 | 97,986 |
Retained earnings | 138,573 | 132,235 |
Accumulated other comprehensive losses | (37,896) | (43,092) |
Unearned ESOP shares | (174) | (174) |
Total Stockholders’ Equity | 198,806 | 187,011 |
Total Liabilities and Stockholders’ Equity | 2,428,536 | 2,410,017 |
U.S. SBA PPP | ||
Assets | ||
Net U.S. Small Business Administration ("SBA") Paycheck Protection Program ("PPP") Loans | 0 | 339 |
Portfolio Loans | ||
Assets | ||
Net loans | $ 1,820,806 | $ 1,798,178 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | |
Allowance for loan losses | $ 23,515 | $ 22,890 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, authorized (in shares) | 15,000,000 | 15,000,000 |
Common stock, issued (in shares) | 5,666,904 | 5,648,435 |
Subordinated Debt | ||
Subordinated notes interest rate | 4.75% |
CONSOLIDATED STATEMENTS OF INCO
CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Interest and Dividend Income | ||
Loans, including fees | $ 23,116 | $ 15,610 |
Interest and dividends on investment securities | 3,992 | 1,666 |
Interest on deposits with banks | 156 | 60 |
Total Interest and Dividend Income | 27,264 | 17,336 |
Interest Expense | ||
Deposits | 6,729 | 513 |
Short-term borrowings | 998 | 0 |
Long-term debt | 469 | 354 |
Total Interest Expense | 8,196 | 867 |
Net Interest Income | 19,068 | 16,469 |
Provision for credit losses | 670 | 450 |
Provision for unfunded commitments | (18) | (31) |
Net Interest Income After Provision For Credit Losses | 18,416 | 16,050 |
Noninterest Income | ||
Unrealized gains (losses) on equity securities | 69 | (222) |
Income from bank owned life insurance | 217 | 214 |
Net gains (losses) on sale of loans originated for sale | 1 | (4) |
Total Noninterest Income | 1,449 | 1,451 |
Noninterest Expense | ||
Compensation and benefits | 5,481 | 5,055 |
Occupancy expense | 847 | 732 |
Advertising | 88 | 64 |
Data processing expense | 1,037 | 1,007 |
Professional fees | 835 | 731 |
Merger and acquisition costs | 259 | 0 |
Depreciation of premises and equipment | 177 | 149 |
FDIC Insurance | 180 | 179 |
OREO valuation allowance and expenses | 0 | 6 |
Core deposit intangible amortization | 84 | 109 |
Fraud losses | 28 | 40 |
Other expenses | 1,154 | 1,008 |
Total Noninterest Expense | 10,170 | 9,080 |
Income before income taxes | 9,695 | 8,421 |
Income tax expense | 2,368 | 2,133 |
Net Income | $ 7,327 | $ 6,288 |
Earnings Per Common Share | ||
Basic (in dollars per share) | $ 1.30 | $ 1.11 |
Diluted (in dollars per share) | 1.30 | 1.10 |
Cash dividends paid per common share (in dollars per share) | $ 0.175 | $ 0.175 |
Loan appraisal, credit, and miscellaneous charges | ||
Noninterest Income | ||
Revenue | $ 93 | $ 176 |
Service charges | ||
Noninterest Income | ||
Revenue | 1,069 | 926 |
Referral fee income | ||
Noninterest Income | ||
Revenue | $ 0 | $ 361 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/LOSS (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Net Income | $ 7,327 | $ 6,288 |
Net unrealized holding gains (losses) arising during period, net of tax expenses (benefits) of $2,751 and $(5,998), respectively. | 5,196 | (17,017) |
Comprehensive Income (Loss) | $ 12,523 | $ (10,729) |
CONSOLIDATED STATEMENTS OF CO_2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Net unrealized holding (loss) gains arising during period, tax effect | $ 2,751 | $ (5,998) |
CONSOLIDATED STATEMENTS OF CHAN
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands | Total | Cumulative Effect, Period of Adoption, Adjustment | Common Stock | Additional Paid-in Capital | Retained Earnings | Retained Earnings Cumulative Effect, Period of Adoption, Adjustment | Accumulated Other Comprehensive Income (Loss) | Unearned ESOP Shares |
Beginning Balance at Dec. 31, 2021 | $ 208,133 | $ (2,006) | $ 57 | $ 96,896 | $ 113,448 | $ (2,006) | $ (1,952) | $ (316) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Net Income | 6,288 | 6,288 | ||||||
Unrealized holding loss on investment securities, net of tax | (17,017) | (17,017) | ||||||
Cash dividends | (949) | (949) | ||||||
Dividend reinvestment | 0 | 52 | (52) | |||||
Net change in fair market value below cost of leveraged ESOP shares released | 6 | 6 | ||||||
Repurchase of common stock | (1,550) | (1,550) | ||||||
Stock based compensation | 235 | 235 | ||||||
Ending Balance at Mar. 31, 2022 | $ 193,140 | 57 | 97,189 | 115,179 | (18,969) | (316) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Accounting Standards Update [Extensible List] | Accounting Standards Update 2016-13 [Member] | |||||||
Beginning Balance at Dec. 31, 2022 | $ 187,011 | 56 | 97,986 | 132,235 | (43,092) | (174) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Net Income | 7,327 | 7,327 | ||||||
Unrealized holding loss on investment securities, net of tax | 5,196 | 5,196 | ||||||
Cash dividends | (931) | (931) | ||||||
Dividend reinvestment | 0 | 58 | (58) | |||||
Net change in fair market value below cost of leveraged ESOP shares released | 5 | 5 | ||||||
Stock based compensation | 198 | 1 | 197 | |||||
Ending Balance at Mar. 31, 2023 | $ 198,806 | $ 57 | $ 98,246 | $ 138,573 | $ (37,896) | $ (174) |
CONSOLIDATED STATEMENTS OF CH_2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Stockholders' Equity [Abstract] | ||
Net unrealized holding gains (losses) arising during period, tax effect | $ 2,751 | $ (5,998) |
Cash dividends (in dollars per share) | $ 0.175 | $ 0.175 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Cash Flows from Operating Activities | ||
Net income | $ 7,327 | $ 6,288 |
Adjustments to reconcile net income to net cash provided by operating activities | ||
Provision for credit losses | 670 | 450 |
Provision for unfunded commitments | (18) | (31) |
Depreciation and amortization | 489 | 373 |
Loans originated for resale | (218) | (1,606) |
Proceeds from sale of loans originated for sale | 219 | 1,255 |
Net (gains) losses on sale of loans held for sale | (1) | 4 |
Unrealized (gains) losses on equity securities | (69) | 222 |
Net amortization of premium/discount on investment securities | 356 | 582 |
Net accretion of merger accounting adjustments | (23) | (62) |
Net amortization of debt issuance costs | 14 | 14 |
Amortization of core deposit intangible | 84 | 109 |
Amortization of right of use asset | 103 | 91 |
Net change in right of use assets and lease liabilities | (88) | (77) |
Increase in cash surrender value of bank owned life insurance | (217) | (213) |
(Decrease) increase in deferred income tax benefit | (7) | 206 |
(Increase) decrease in accrued interest receivable | (191) | 199 |
Stock based compensation | 198 | 235 |
Net change in fair market value above cost of leveraged ESOP shares released | 5 | 6 |
(Increase) decrease in net deferred loan costs | (851) | 283 |
(Decrease) increase in accrued expenses and other liabilities | (1,545) | 586 |
Decrease in other assets | 1,839 | 1,781 |
Net Cash Provided by Operating Activities | 8,076 | 10,695 |
Cash Flows from Investing Activities | ||
Purchase of AFS investment securities | (26) | (46,404) |
Proceeds from redemption or principal payments of AFS investment securities | 6,388 | 13,107 |
Net decrease (increase) of FHLB stock | 2,403 | (214) |
Net change in loans | (22,083) | (39,828) |
Purchase of premises and equipment | (168) | (250) |
Net Cash Used in Investing Activities | (13,486) | (73,589) |
Cash Flows from Financing Activities | ||
Net increase in deposits | 65,860 | 38,919 |
Payments of long-term debt | 0 | (18) |
Net decrease in short term borrowings | (57,500) | 0 |
Dividends paid | (931) | (949) |
Repurchase of common stock | 0 | (1,550) |
Net Cash Provided by Financing Activities | 7,429 | 36,402 |
Increase (Decrease) in Cash and Cash Equivalents | 2,019 | (26,492) |
Cash and Cash Equivalents - January 1 | 25,473 | 139,654 |
Cash and Cash Equivalents - March 31 | 27,492 | 113,162 |
Cash paid during the period for | ||
Interest | 7,632 | 637 |
Income taxes | 0 | 0 |
Supplemental Schedule of Non-Cash Operating Activities | ||
Issuance of common stock for payment of compensation | 616 | 130 |
Supplemental Schedule of Non-Cash Investing and Financing Activities | ||
Cumulative effect adjustment for adoption of ASU 2016-13 | $ 0 | $ 2,006 |
Basis of Presentation and Natur
Basis of Presentation and Nature of Operations | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation and Nature of Operations | BASIS OF PRESENTATION AND NATURE OF OPERATIONS Basis of Presentation The Consolidated Financial Statements include the accounts of The Community Financial Corporation and its wholly-owned subsidiary, Community Bank of the Chesapeake (the “Bank”), (collectively, the “Company”), included herein are unaudited. The Consolidated Financial Statements reflect all adjustments consisting only of normal recurring accruals that, in the opinion of management, are necessary to present fairly the Company’s financial condition, results of operations, and cash flows for the periods presented. Certain information and note disclosures normally included in Consolidated Financial Statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to the rules and regulations of the SEC. Management believes that the included disclosures are adequate to make the information presented not misleading. The balances as of December 31, 2022 have been derived from audited Consolidated Financial Statements. The Company’s accounting policies are disclosed in Note 1 to the 2022 Consolidated Financial Statements. The results of operations for the three months March 31, 2023 are not necessarily indicative of the results of operations to be expected for the remainder of the year or any other period. These Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes included in the Company’s 2022 Annual Report on Form 10-K. Reclassification Certain items in prior Consolidated Financial Statements have been reclassified to conform to the current presentation. Nature of Operations The Company provides financial services to individuals and businesses through its offices in Southern Maryland and Fredericksburg, Virginia. Its primary deposit products are demand, savings and time deposits, and its primary lending products are commercial and residential mortgage loans, commercial loans, construction and land development loans, home equity and second mortgages and commercial equipment loans. Use of Estimates The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the Consolidated Financial Statements and the reported amount of income and expenses during the reporting periods. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for credit losses ("ACL"), real estate acquired in the settlement of loans ("OREO"), fair value of financial instruments, fair value of assets acquired, and liabilities assumed in a business combination, evaluating potential credit losses of investment securities and valuation of deferred tax assets. Loans Loans that the Company has the intent and ability to hold for the foreseeable future, or until maturity or payoff, are reported at their outstanding unpaid principal balances, adjusted for the allowance for credit losses and any deferred fees or premiums. Interest income is accrued on the unpaid principal balance. Loan origination fees and premiums, net of certain direct origination costs, are deferred and recognized as an adjustment of the related loan yield using the interest method. Loans purchased with evidence of credit deterioration since origination and for which it is probable that all contractually required payments will not be collected are considered credit deteriorated. Evidence of credit quality deterioration as of the purchase date may include statistics such as internal risk grade, past due and nonaccrual status, recent borrower credit scores and recent loan-to-value (“LTV”) percentages. The Company considers a loan to be past due or delinquent when the terms of the contractual obligation are not met by the borrower. Loans are reviewed on a regular basis and are placed on non-accrual status when, in the opinion of management, the collection of additional interest is doubtful. The accrual of interest on mortgage and commercial loans is discontinued at the time the loan is 90 days delinquent unless the credit is well secured and in the process of collection. Non-accrual loans include certain loans that are current with all loan payments and are placed on non-accrual status due to customer operating results and cash flows. Non-accrual loans are evaluated for impairment on a loan-by-loan basis in accordance with the Company’s impairment methodology. Consumer loans, excluding credit card loans, are typically charged-off no later than 90 days past due. Credit card loans are typically charged-off no later than 180 days past due. Mortgage and commercial loans are fully or partially charged-off when in management’s judgment all reasonable efforts to return a loan to performing status have occurred. In all cases, loans are placed on non-accrual or charged-off at an earlier date if collection of principal or interest is considered doubtful. All interest accrued but not collected from loans that are placed on non-accrual or charged-off is reversed against interest income. The interest on these loans is accounted for on the cash-basis or cost-recovery method, until qualifying for return to accrual status. Loans are returned to accrual status when all principal and interest amounts contractually due are brought current and future payments are reasonably assured. Modifications to borrowers experiencing financial difficulty (BEFD) are loans that have been modified to provide for a reduction or a delay in the payment of either interest or principal because of deterioration in the financial condition of the borrower. A loan extended or renewed at a stated interest rate equal to the current interest rate for new debt with similar risk is not considered a BEFD modification. Once an obligation has been classified as a BEFD modification it continues to be considered a BEFD modification until paid in full or until the debt is refinanced and considered unimpaired. All BEFD modifications are assessed on a loan-by-loan basis. The Company does not participate in any specific government or Company-sponsored loan modification programs. All restructured loan agreements are individual contracts negotiated with a borrower. Allowance for Credit Losses - Loans The ACL is an estimate of the expected credit losses for loans held for investment and off-balance sheet exposures. Accounting Standards Codification ("ASC") 326, "Financial Instruments-Credit Losses" requires an immediate recognition of the credit loss expected to occur over the lifetime of a financial asset whether originated or purchased. Charge-offs are recorded to the ACL when management believes the loan is uncollectible. Subsequent recoveries, if any, are credited to the ACL. Management believes the ACL is in accordance with U.S. GAAP and in compliance with appropriate regulatory guidelines. The ACL includes quantitative estimates of losses for collectively and individually evaluated loans. As more fully described below, the model-based quantitative estimate for collectively evaluated loans is determined using the probability of default ("PD") and loss given default ("LGD") at the segment level and applied at the loan level against the expected exposure at default ("EAD"). Qualitative adjustments to the quantitative estimate may be made using information not considered in the quantitative model. The Bank uses a range of data to estimate expected credit losses under CECL, including information about past events, current conditions, and reasonable and supportable forecasts relevant to assessing the collectability of the cash flows of the loans. Historical loss experience serves as the foundation for our estimated credit losses. Adjustments to our historical loss experience are made for differences in current loan portfolio segment credit risk characteristics such as the impact of changing unemployment rates, changes in U.S. Treasury yields, portfolio concentrations, the volume of classified loans, inflation, and other prevailing economic conditions and factors that may affect the borrower’s ability to repay, or reduce the estimated value of underlying collateral. This evaluation is inherently subjective, as it requires estimates that are susceptible to significant revision as more information becomes available. The ACL is measured on a collective basis when similar risk characteristics exist. Generally, collectively assessed loans are grouped by loan type code or product type codes and assigned to a corresponding portfolio segment. Portfolio segments may be further subdivided into similar risk profile groupings based on interest rate structure, types of collateral or other terms and characteristics. The probability of default (“PD”) calculation analyzes the historical loan portfolio over the given look back period to identify, by segment, loans that have defaulted. A default is defined as a loan that has moved to past due 90 days and greater, nonaccrual status, or experienced a charge-off during the period. The model observes loans over a 12-month window, detecting any events previously defined. This information is then used by the model to calculate annual iterative count-based PD rates for each segment. This process is then repeated for all dates within the historical data range. These averaged PD’s are used for a 12-month straight-line reversion to the historical mean. The historical data used was from mid-2006 through the most recent quarter end. The Company utilizes reasonable and supportable forecasts of future economic conditions when estimating the ACL on loans. The model’s calculation also includes a 12-month forecasted PD based on a regression model that compares the Company’s historical loan data to various national economic metrics during the same periods. The results show the Company’s past losses having a high rate of correlation to national unemployment rates for fixed rate loans and the 10-Year U.S. Treasury for adjustable-rate loans. The model uses this information, along with the most recently published Wall Street Journal survey of sixty economists’ forecasts predicting unemployment rates out over the next four quarters to estimate the PD for the forward-looking 12-month period. These data are also used to predict credit losses at different levels of stress, including a baseline, low, high and adverse economic conditions. After the forecast period, PD rates revert to the historical mean straight line over a 12-month period for the entire data set. The loss given default (“LGD”) calculation is based on actual losses (charge-offs, net of recoveries) at a loan level over the entire look-back period aggregated for each loan segment. The aggregate loss is divided by the exposure at default to determine an LGD rate. Defaults occurring during the look-back period are included in the denominator, whether or not a loss occurred and exposure at default is determined by the loan balance immediately preceding the default event. When the Company's data are insufficient. an industry index is used. The exposure at default (“EAD”) calculation projects future expected balances from monthly cash flow schedules to apply PD and LGD assumptions. These are derived based on current contractual terms (balance, interest rate, payment structure), adjusted for expected voluntary prepayments. The contractual terms exclude expected extensions, renewals and modifications unless either of the following applies: management has the reasonable expectation that a loan will be restructured, or the extension or renewal option are included in the borrower contract. On a quarterly basis, the Company uses internal portfolio credit data, such as levels of non-accrual loans, classified assets and concentrations of credit along with other external information not used in the quantitative calculation to determine qualitative adjustments. Loans that do not share the same common risk characteristics with other loans are individually assessed. Such loans include non-accrual loans, BEFD modifications, loans classified as substandard or worse, loans that are greater than 89 days delinquent and any other loan identified by management for individual assessment. Reserves on individually assessed loans are measured on a loan-by-loan basis. Generally, consumer loans, including credit cards, are not individually assessed as the Bank's policy is to charge-off credit card loans when they become 180 days delinquent and other consumer loans when they are more than 90 days delinquent. The methodology used to estimate the ACL is designed to be responsive to changes in portfolio credit quality and forecasted economic conditions. Changes due to new information are reflected in the pool-based allowance and in reserves assigned on an individual basis. Executive management closely monitors loss ratios, reviews the appropriateness of the ACL and presents conclusions to the Credit Risk Committee and the Audit Committee. The committees report to the Board as part of Board's quarterly review of our regulatory reporting and consolidated financial statements. The calculation of the ACL excludes accrued interest receivable balances because these balances are reversed in a timely manner against previously recognized interest income when a loan is placed on non-accrual status. Allowance for Credit Losses - AFS Debt securities The Company does not presently hold any HTM debt securities and therefore is not presently required to apply a CECL methodology for an HTM investment portfolio. The impairment model for AFS debt securities measures fair value. Although ASU No. 2016-13 replaced the legacy other-than-temporary impairment (“OTTI”) model with a credit loss model, it retained the fundamental nature of the legacy OTTI model for AFS securities. One notable change from the legacy OTTI model is when evaluating whether credit loss exists, an entity may no longer consider the length of time fair value has been less than amortized cost. For AFS debt securities in an unrealized loss position, the Company first assesses whether it intends to sell, or it is more likely than not that it will be required to sell the security before recovery of its amortized cost basis. If either criterion is met, the security’s amortized cost basis is written down to fair value through income. For AFS debt securities that do not meet the aforementioned criteria, the Company evaluates whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, management considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and a corresponding allowance for credit losses is recorded. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income. Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit losses. Losses are charged against the allowance when management believes the uncollectibility of an AFS security is confirmed or when either of the criteria regarding intent or requirement to sell is met. Any impairment not recorded through an allowance for credit loss is recognized in other comprehensive income as a noncredit-related impairment. As of March 31, 2023, the Company determined that the unrealized loss positions in AFS securities were not the result of credit losses, and therefore, an allowance for credit losses was not recorded. See Note 2 Investment Securities for more information. The Bank elected to exclude accrued interest from the amortized cost basis of AFS debt securities and report accrued interest separately in accrued interest and other assets in the consolidated balance sheets. AFS debt securities are placed on non-accrual status when management no longer expects to receive all contractual amounts due, which is generally at 90 days past due. Accrued interest receivable is reversed against interest income when a security is placed on non-accrual status. Accordingly, the Company does not recognize an allowance for credit loss against accrued interest receivable. The majority of AFS debt securities as of March 31, 2023 and December 31, 2022 were issued by Government Sponsored Enterprises (“GSEs”) and U.S. agencies. As such, an allowance for credit losses is not considered necessary. Collateral Dependent Financial Assets Loans that do not share risk characteristics are evaluated on an individual basis. For collateral dependent financial assets where the Company has determined that foreclosure of the collateral is probable, or where the borrower is experiencing financial difficulty and the Company expects repayment of the financial asset to be provided substantially through the operation or sale of the collateral, the ACL is measured based on the difference between the fair value of the collateral and the amortized cost basis of the asset as of the measurement date. When repayment is expected to be from the operation of the collateral, expected credit losses are calculated as the amount by which the amortized cost basis of the financial asset exceeds the Net Present Value ("NPV") from the operation of the collateral. When repayment is expected to be from the sale of the collateral, expected credit losses are calculated as the amount by which the amortized costs basis of the financial asset exceeds the fair value of the underlying collateral less estimated cost to sell. The ACL may be zero if the fair value of the collateral at the measurement date exceeds the amortized cost basis of the financial asset. Subsequent changes to the fair value of collateral, for which an ACL was previously recognized, will be reported as a provision (recovery) for credit losses. The Bank generally uses the practical expedient of the fair value of the collateral, net of estimated selling costs, to determine the expected credit loss for individually assessed collateral dependent loans. Loan Commitments and Allowance for Credit Losses on Off-Balance Sheet Credit Exposure Financial instruments include off-balance sheet credit instruments such as commitments to make loans and commercial letters of credit issued to meet customer financing needs. The Company's exposure to credit loss in the event of nonperformance by the other party to the financial instrument for off-balance sheet loan commitments is represented by the contractual amount of those instruments. Such financial instruments are recorded when they are funded. The Company records a reserve for unfunded commitments (“RUC”) on off-balance sheet credit exposures through a charge to provision for credit loss expense in the Company’s consolidated statements of operations. The RUC on off-balance sheet credit exposures is estimated by loan segment at each balance sheet date under the CECL model using the same methodologies as portfolio loans, taking into consideration the likelihood that funding will occur, and is included in Other Liabilities on the Company’s consolidated balance sheets. See Note 1 – Summary of Significant Accounting Policies included in the Company’s 2022 Annual Report on Form 10-K for a list of policies in effect as of December 31, 2022. Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) Adopted New Accounting Standard ASU 2020-04 – Reference Rate Reform (Topic 848 ). In March 2020, the FASB issued guidance to provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. The amendments are effective as of March 12, 2020 through December 31, 2024, as deferred under ASU 2022-06 - Reference Rate Reform (Topic 848) Deferral of the Sunset Date of Topic 848. The amendments did not have a material effect on its Consolidated Financial Statements. ASU Update 2022-02 – On January 1, 2023, the Company adopted ASU 2022-02 – Financial Instruments-Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures. ASU 2022-02 eliminates the TDRs recognition and measurement guidance and, instead requires that an entity evaluate whether the modification represents a new loan or a continuation of an existing loan. The amendments enhance existing disclosure requirements and introduce new requirements related to certain modifications of receivables made to borrowers experiencing financial difficulty. In addition, ASU Update 2022-02 requires that an entity disclose current-period gross write-offs by year of origination for financing receivables and net investment in leases. The Company adopted ASU 2022-02 using a modified retrospective transition method for TDRs. The impact of adoption was immaterial. The disclosure amendments in the Update 2022-02 will be applied prospectively. |
Investment Securities
Investment Securities | 3 Months Ended |
Mar. 31, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Investment Securities | INVESTMENT SECURITIES Amortized cost and fair values of investment securities at March 31, 2023 and December 31, 2022 are summarized as follows: March 31, 2023 (dollars in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value AFS Securities Asset-backed securities issued by GSEs and U.S. Agencies Residential Mortgage Backed Securities ("MBS") $ 125,680 $ 11 $ 11,660 $ 114,031 Residential Collateralized Mortgage Obligations ("CMOs") 173,344 7 14,623 158,728 U.S. Agency 14,714 — 2,029 12,685 Asset-backed securities ("ABSs") issued by Others: Residential CMOs 12,369 3 373 11,999 Student Loan Trust ABSs 46,771 29 1,866 44,934 Municipal bonds 99,686 — 16,794 82,892 Corporate bonds 4,867 — 504 4,363 U.S. government obligations 36,851 1 2,535 34,317 Total AFS Securities $ 514,282 $ 51 $ 50,384 $ 463,949 Equity securities carried at fair value through income CRA investment fund $ 4,380 $ — $ — $ 4,380 Non-marketable equity securities Other equity securities $ 207 $ — $ — $ 207 Total Investment Securities $ 518,869 $ 51 $ 50,384 $ 468,536 December 31, 2022 (dollars in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value AFS Securities Asset-backed securities issued by GSEs and U.S. Agencies Residential MBS $ 126,861 $ 12 $ 13,203 $ 113,670 Residential CMOs 175,905 8 16,500 159,413 U.S. Agency 14,658 — 2,302 12,356 Asset-backed securities issued by Others: Residential CMOs 12,593 13 400 12,206 Student Loan Trust ABSs 49,566 39 2,293 47,312 Municipal bonds 99,766 — 20,148 79,618 Corporate bonds 4,863 — 459 4,404 U.S. government obligations 36,813 1 3,047 33,767 Total AFS Securities $ 521,025 $ 73 $ 58,352 $ 462,746 Equity securities carried at fair value through income CRA investment fund $ 4,286 $ — $ — $ 4,286 Non-marketable equity securities Other equity securities $ 207 $ — $ — $ 207 Total Investment Securities $ 525,518 $ 73 $ 58,352 $ 467,239 The Company elected to exclude accrued interest receivable (“AIR”) from the amortized cost basis of debt securities disclosed throughout this footnote. AFS debt securities, AIR totaled $1.8 million and $1.8 million as of March 31, 2023, and December 31, 2022, respectively. AIR is included in the “accrued interest receivable” line item on the Company’s consolidated balance sheets. At March 31, 2023 and December 31, 2022, securities with an amortized cost of $58.3 million and $56.4 million were pledged to secure certain customer deposits. During the quarters ended March 31, 2023 and December 31, 2022, the Company did not sell any securities. Management does not believe that the AFS debt securities in an unrealized loss position as of March 31, 2023 have credit loss impairment. As of March 31, 2023, and December 31, 2022, the gross unrealized loss positions were primarily related to mortgage-backed securities issued by U.S. government agencies or U.S. government sponsored enterprises. These securities carry the explicit and/or implicit guarantee of the U.S. government, are widely recognized as “risk free,” and have a long history of zero credit loss. The Company also performed credit reviews on municipal bonds issued by States and Political Subdivisions and asset backed securities issued by Student Loan Trust. Total gross unrealized losses were primarily attributable to changes in interest rates, relative to when the investment securities were purchased, and not due to the credit quality of the investment securities. The Company does not intend to sell the investment securities that were in an unrealized loss position, and it is not more likely than not that the Company will be required to sell the investment securities before recovery of their amortized cost basis, which may be at maturity. Management believes that the securities will either recover in market value or be paid off as agreed. AFS Securities Gross unrealized losses and estimated fair value by length of time that individual AFS securities have been in a continuous unrealized loss position at March 31, 2023 and December 31, 2022 were as follows: March 31, 2023 Less Than 12 Months More Than 12 Months Total (dollars in thousands) Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Losses Asset-backed securities issued by GSEs and U.S. Agencies $ 9,383 $ 543 $ 273,811 $ 27,769 $ 283,194 $ 28,312 Asset-backed securities issued by Others 10,266 353 129 20 10,395 373 Student Loan Trust ABSs — — 40,076 1,866 40,076 1,866 Municipal bonds 1,107 10 81,785 16,784 82,892 16,794 Corporate bonds 1,861 6 2,502 498 4,363 504 U.S. government obligations — — 32,333 2,535 32,333 2,535 $ 22,617 $ 912 $ 430,636 $ 49,472 $ 453,253 $ 50,384 December 31, 2022 Less Than 12 Months More Than 12 Months Total (dollars in thousands) Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Losses Asset-backed securities issued by GSEs and U.S. Agencies $ 24,688 $ 1,493 $ 259,127 $ 30,512 $ 283,815 $ 32,005 Asset-backed securities issued by Others 7,469 381 138 19 7,607 400 Student Loan Trust ABSs 1,950 1 42,170 2,292 44,120 2,293 Municipal bonds 6,695 796 72,923 19,352 79,618 20,148 Corporate bonds 4,404 459 — — 4,404 459 U.S. government obligations 18,764 1,137 13,041 1,910 31,805 3,047 $ 63,970 $ 4,267 $ 387,399 $ 54,085 $ 451,369 $ 58,352 Maturities The amortized cost and estimated fair value of debt securities at March 31, 2023 and December 31, 2022 by contractual maturity, are shown below. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call premiums or prepayment penalties. March 31, 2023 December 31, 2022 (dollars in thousands) Amortized Cost Estimated Fair Value Amortized Cost Estimated Fair Value Within one year $ 37,444 $ 33,780 $ 35,441 $ 31,477 Over one year through five years 132,267 119,322 136,449 121,186 Over five years through ten years 224,597 202,615 228,997 203,383 After ten years 119,974 108,232 120,138 106,700 Total AFS securities $ 514,282 $ 463,949 $ 521,025 $ 462,746 |
Loans
Loans | 3 Months Ended |
Mar. 31, 2023 | |
Receivables [Abstract] | |
Loans | LOANS Portfolio loans, net of deferred costs and fees, are summarized by type as follows at March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 (dollars in thousands) Total % of Total Loans Total % of Total Loans Portfolio Loans: Commercial real estate $ 1,265,519 68.63 % $ 1,232,826 67.69 % Residential first mortgages 78,186 4.24 % 79,872 4.39 % Residential rentals 329,417 17.86 % 338,292 18.58 % Construction and land development 18,474 1.00 % 17,259 0.95 % Home equity and second mortgages 25,492 1.38 % 25,602 1.41 % Commercial loans 40,666 2.20 % 42,055 2.31 % Consumer loans 7,271 0.39 % 6,272 0.34 % Commercial equipment 79,296 4.30 % 78,890 4.33 % Total portfolio loans (1) 1,844,321 100.00 % 1,821,068 100.00 % Less: Allowance for Credit Losses (23,515) (1.27) % (22,890) (1.26) % Total net portfolio loans 1,820,806 1,798,178 U.S. SBA PPP loans (1) — 339 Total net loans $ 1,820,806 $ 1,798,517 ___________________________________________ (1) Excludes accrued interest receivable of $6.8 million and $6.6 million, at March 31, 2023 and December 31, 2022, respectively. The Company has segregated its loans into portfolio loans and U.S. SBA PPP loans at December 31, 2022. Deferred Costs/Fees Portfolio net deferred fees of $3.9 million at March 31, 2023 included deferred fees paid by customers of $8.3 million offset by deferred costs of $4.4 million. Deferred loan costs include premiums paid for the purchase of residential first mortgages and deferred loan origination costs in accordance with ASC 310-20. Net deferred loan fees of $3.0 million at December 31, 2022 included deferred fees paid by customers of $7.3 million offset by deferred costs of $4.3 million. U.S. SBA PPP net deferred loan fees of $8,000 at December 31, 2022 included deferred fees paid by the SBA of $9,000 offset by deferred costs of $1,000. The net deferred fees are being amortized as a component of interest income through the contractual maturity date of each U.S. SBA PPP loan. Net deferred fees include fees received by participant banks for each U.S. SBA PPP loan underwritten and funded net of costs incurred to underwrite the loans. Net deferred fees will be recognized in income when the U.S. SBA PPP loan is forgiven or paid. Risk Characteristics of Portfolio Segments Concentrations of Credit - Loans are primarily made within the Company’s operating footprint of Southern Maryland and the greater Fredericksburg area of Virginia. Real estate loans can be affected by the condition of the local real estate market. Commercial and industrial loans can be affected by the local economic conditions. The commercial loan portfolio has business loans secured by real estate and real estate development loans. At March 31, 2023 and December 31, 2022, the Company had no loans outstanding with foreign entities. The Company manages its credit products and exposure to credit losses (credit risk) by the following specific portfolio segments (classes), which are levels at which the Company develops and documents its allowance for loan loss methodology. These segments are: Commercial Real Estate (“CRE”) Commercial and other real estate projects include office, medical and professional buildings, retail locations, churches, other special purpose buildings and commercial construction. Commercial construction balances were 6.2% and 6.9% of the CRE portfolio at March 31, 2023 and December 31, 2022, respectively. The Bank offers both fixed-rate and adjustable-rate loans under these product lines. During periods of rising interest rates, the risk of default on adjustable-rate mortgage loans may increase due to the upward adjustment of interest cost to the borrower. The Bank’s adjustable rate CRE portfolio was $914.8 million or 49.6% of total portfolio loans of $1.8 billion at March 31, 2023 compared to $918.4 million or 50.4% of total gross portfolio loans of $1.82 billion at December 31, 2022. The primary security on a commercial real estate loan is the real property and the leases that produce income for the real property. Loans secured by commercial real estate are generally limited to 80% of the lower of the appraised value or sales price at origination and have an initial contractual loan payment period ranging from three Because payments on loans secured by such properties are often dependent on the successful operation or management of the properties, repayment of such loans may be subject to adverse conditions in the real estate market or the economy. Residential First Mortgages Residential first mortgage loans are generally long-term (10 to 30 years) amortizing loans. The Bank’s residential portfolio has both fixed-rate and adjustable-rate residential first mortgages. The annual and lifetime limitations on interest rate adjustments may constrain interest rate increases on these loans. There are also credit risks resulting from potential increased costs to the borrower as a result of repricing of adjustable-rate mortgage loans. During periods of rising interest rates, the risk of default on adjustable-rate mortgage loans may increase due to the upward adjustment of interest cost to the borrower. The Bank’s adjustable rate residential first mortgage portfolio was $12.9 million or 0.7% of total portfolio loans of $1.8 billion at March 31, 2023 compared to $13.1 million or 0.7% of total gross portfolio loans of $1.82 billion at December 31, 2022. The Bank generally retains the right to service loans sold for a payment based upon a percentage (generally 0.25% of the outstanding loan balance). As of March 31, 2023 and December 31, 2022, the Bank serviced $19.1 million and $19.5 million, respectively, in residential mortgage loans for others. Residential Rentals Residential rental mortgage loans are amortizing long-term loans. Loans secured by residential rental properties are generally limited to 80% of the lower of the appraised value or sales price at origination and have an initial contractual loan payment period ranging from three Loans secured by residential rental properties involve greater risks than 1-4 family residential mortgage loans. Although, there are similar risk characteristics shared with commercial real estate loans, the balances for the loans secured by residential rental properties are generally smaller. Payments on loans secured by residential rental properties are dependent on the successful operation of the properties; and repayment of these loans may be subject to adverse conditions in the rental real estate market or the economy than similar owner-occupied properties. Construction and Land Development The Bank offers loans for the construction of residential dwellings. These loans are secured by the real estate under construction as well as by guarantees of the principals involved. In addition, the Bank offers loans to acquire and develop land. Construction and Land Development loans are dependent on the successful completion of the underlying project, or the borrowers guarantee to repay the loan. As such, they are subject to the risks of the project including the borrower’s ability to successfully manage construction and development activities. The repayment of these loans is also subject to economic risks such as changing prices and interest rates. Home Equity and Second Mortgage Loans The Bank maintains a portfolio of home equity and second mortgage loans. These products contain a higher risk of default than residential first mortgages as in the event of foreclosure, the first mortgage would need to be paid off prior to collection of the second mortgage. Commercial Loans Commercial loans including lines of credit are short-term loans (5 years or less) that are secured by the equipment financed, the guarantees of the borrower, and other collateral. These loans are dependent on the success of the underlying business or the strength of the guarantor. Consumer Loans Consumer loans consist of loans secured by automobiles, boats, recreational vehicles and trucks. The Bank also makes home improvement loans and offers both secured and unsecured personal lines of credit and credit card loans. The repayment of these loans is dependent on the continued financial stability of the customer. Commercial Equipment Loans These loans consist primarily of fixed-rate, short-term loans collateralized by a commercial customer’s equipment or secured by real property, accounts receivable, or other security as determined by the Bank. Commercial loans are dependent on the success of the underlying business or the strength of the guarantor. U.S. SBA PPP Loans U.S. SBA PPP loans are fully guaranteed by the Small Business Administration and the Bank's ACL does not include an allowance for U.S. SBA PPP loans. Management believes all U.S. SBA PPP loans were underwritten in accordance with the program's guidelines. Loans Non-accrual loans as of March 31, 2023 and December 31, 2022 were as follows: March 31, 2023 (dollars in thousands) Nonaccrual with No Allowance for Credit Losses Nonaccrual with Allowance for Credit Losses Total Nonaccrual Loans Commercial real estate $ 4,498 $ 1,391 $ 5,889 Residential rentals 1,631 — 1,631 Home equity and second mortgages 444 — 444 Consumer loans — 9 9 Commercial equipment 124 27 151 Total $ 6,697 $ 1,427 $ 8,124 Interest Income on Nonaccrual Loans $ 63 $ — $ 63 December 31, 2022 (dollars in thousands) Nonaccrual with No Allowance for Credit Losses Nonaccrual with Allowance for Credit Losses Total Nonaccrual Loans Commercial real estate $ 4,521 $ 81 $ 4,602 Residential rentals 1,142 — 1,142 Home equity and second mortgages 206 — 206 Commercial equipment 137 28 165 Total $ 6,006 $ 109 $ 6,115 Interest Income on Nonaccrual Loans $ 121 $ — $ 121 March 31, 2023 (dollars in thousands) Non-accrual Delinquent Loans Non-accrual Current Loans Total Non-accrual Loans Commercial real estate $ — $ 5,889 $ 5,889 Residential rentals 274 1,357 1,631 Home equity and second mortgages 444 — 444 Consumer loans 9 — 9 Commercial equipment — 151 151 $ 727 $ 7,397 $ 8,124 December 31, 2022 (dollars in thousands) Non-accrual Delinquent Loans Non-accrual Current Loans Total Non-accrual Loans Commercial real estate $ — $ 4,602 $ 4,602 Residential first mortgages — — — Residential rentals 449 693 1,142 Home equity and second mortgages 206 — 206 Commercial equipment — 165 165 U.S. SBA PPP loans — — — $ 655 $ 5,460 $ 6,115 Non-accrual loans increased $2.0 million from $6.1 million or 0.34% of total loans at December 31, 2022 to $8.1 million or 0.44% of total loans at March 31, 2023. Loans can be current but classified as non-accrual due to customer operating results or payment history. All interest accrued but not collected from loans that are placed on non-accrual or charged-off is reversed against interest income. In accordance with the Company’s policy, such interest income is recognized on a cash basis or cost-recovery method, until qualifying for return to accrual status. At December 31, 2022, there were $5.5 million (89%) of non-accrual loans were current with all payments of principal and interest with specific reserves of $0.1 million and $0.7 million (11%) of non-accrual loans were delinquent with no specific reserves. Non-accrual loans at March 31, 2023 and December 31, 2022 included no delinquent BEFD modifications. Non-accrual loans on which the recognition of interest has been discontinued, which did not have a specific allowance for impairment, amounted to $6.7 million and $6.0 million at March 31, 2023 and December 31, 2022, respectively. Interest due but not recognized on these balances at March 31, 2023 and December 31, 2022 was $43,000 and $22,000, respectively. Non-accrual loans with a specific allowance for impairment amounted to $1.4 million and $0.1 million at March 31, 2023 and December 31, 2022, respectively. Interest due but not recognized on these balances at March 31, 2023 and December 31, 2022 was $5,000 and $1,000, respectively. The Company considers a loan to be past due or delinquent when the terms of the contractual obligation are not met by the borrower. Regardless of payment status, as long as cash flows can be reasonably estimated, the associated discount on these loan pools results in income recognition. An analysis of days past due ("DPD") loans as of March 31, 2023 follows: March 31, 2023 (dollars in thousands) 31-60 DPD 61-89 DPD 90 DPD and Still Accruing 90 DPD and Not Accruing Total Past Due Current Non-Accrual Loans Current Accrual Loans Total Loans Commercial real estate $ 525 $ — $ — $ — $ 525 $ 5,889 $ 1,259,105 $ 1,265,519 Residential first mortgages — — — — — — 78,186 78,186 Residential rentals — — — 274 274 1,357 327,786 329,417 Construction and land development — — — — — — 18,474 18,474 Home equity and second mortgages 263 70 — 205 538 — 24,954 25,492 Commercial loans — — — — — — 40,666 40,666 Consumer loans 66 30 35 — 131 — 7,140 7,271 Commercial equipment — — — — — 151 79,145 79,296 Total Loans $ 854 $ 100 $ 35 $ 479 $ 1,468 $ 7,397 $ 1,835,456 $ 1,844,321 Loan delinquency (total past due) increased $0.4 million from $1.0 million, or 0.06% of loans, at December 31, 2022 to $1.5 million, or 0.08% of loans, at March 31, 2023. An analysis of days past due loans as of December 31, 2022 follows: December 31, 2022 (dollars in thousands) 31-60 DPD 61-89 DPD 90 DPD and Still Accruing 90 DPD and Not Accruing Total Past Due Current Non-Accrual Loans Current Accrual Loans Total Loans Commercial real estate $ 147 $ — $ — $ — $ 147 $ 4,602 $ 1,228,077 $ 1,232,826 Residential first mortgages — — — — — — 79,872 79,872 Residential rentals — 177 — 272 449 693 337,150 338,292 Construction and land development — — — — — — 17,259 17,259 Home equity and second mortgages 53 160 — 116 329 — 25,273 25,602 Commercial loans — — — — — — 42,055 42,055 Consumer loans 21 35 50 — 106 — 6,166 6,272 Commercial equipment 11 — — — 11 165 78,714 78,890 U.S. SBA PPP loans — — — — — — 339 339 Total portfolio loans $ 232 $ 372 $ 50 $ 388 $ 1,042 $ 5,460 $ 1,814,905 $ 1,821,407 Allowance for Credit Losses ("ACL") The following tables detail activity in the ACL at and for the three months ended March 31, 2023 and 2022. An allocation of the allowance to one category of loans does not prevent the Company from using that allowance to absorb losses in a different category. Three Months Ended March 31, 2023 (dollars in thousands) Beginning Balance Charge-offs Recoveries Provisions Ending Balance Commercial real estate $ 17,650 $ — $ 16 $ 726 $ 18,392 Residential first mortgages 207 — — (4) 203 Residential rentals 3,061 — — (156) 2,905 Construction and land development 160 — — 1 161 Home equity and second mortgages 126 — — 5 131 Commercial loans 190 — — 14 204 Consumer loans 154 (44) — 56 166 Commercial equipment 1,342 (21) 4 28 1,353 $ 22,890 $ (65) $ 20 $ 670 $ 23,515 Three Months Ended March 31, 2022 (dollars in thousands) Beginning Balance Impact of ASC 326 Adoption Charge-offs Recoveries Provisions Ending Balance Commercial real estate $ 13,095 $ 3,734 $ — $ — $ 484 $ 17,313 Residential first mortgages 1,002 (679) — — (39) 284 Residential rentals 2,175 (586) — — (43) 1,546 Construction and land development 260 (82) — — (41) 137 Home equity and second mortgages 274 (86) — — (10) 178 Commercial loans 582 (290) — 1 26 319 Consumer loans 58 2 — — 13 73 Commercial equipment 971 483 — 18 60 1,532 $ 18,417 $ 2,496 $ — $ 19 $ 450 $ 21,382 The following table presents the amortized cost basis of collateral-dependent loans by class of loans. March 31, 2023 December 31, 2022 (dollars in thousands) Business/Other Assets Real Estate Business/Other Assets Real Estate Commercial real estate $ — $ 5,889 $ — $ 4,601 Residential rentals — 1,631 — 1,142 Home equity and second mortgages — 444 — 206 Consumer loans 9 — — — Commercial equipment 151 — 595 — Total $ 160 $ 7,964 $ 595 $ 5,949 Credit Quality Indicators Credit quality indicators as of March 31, 2023 were as follows: Credit Risk Profile by Internally Assigned Grade The risk category of loans by class of loans is as follows: Term Loans by Origination Year (dollars in thousands) Prior 2019 2020 2021 2022 2023 Revolving Loans Total Commercial Real Estate Pass $ 393,557 $ 108,531 $ 175,180 $ 261,755 $ 287,060 $ 23,827 $ — $ 1,249,910 Special Mention 4,167 — 5,553 — — — — 9,720 Substandard 2,088 2,960 — 841 — — — 5,889 Total $ 399,812 $ 111,491 $ 180,733 $ 262,596 $ 287,060 $ 23,827 $ — $ 1,265,519 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Residential Rentals Pass $ 46,757 $ 20,527 $ 47,452 $ 72,733 $ 119,293 $ 21,024 $ — $ 327,786 Special Mention — — — — — — — — Substandard 1,631 — — — — — — 1,631 Total $ 48,388 $ 20,527 $ 47,452 $ 72,733 $ 119,293 $ 21,024 $ — $ 329,417 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Construction and Land Development Pass $ 11,181 $ 2,595 $ 631 $ 3,360 $ 148 $ 559 $ — $ 18,474 Special Mention — — — — — — — — Substandard — — — — — — — — Total $ 11,181 $ 2,595 $ 631 $ 3,360 $ 148 $ 559 $ — $ 18,474 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Commercial Loans Pass $ 25,502 $ 2,260 $ 1,985 $ 6,258 $ 3,708 $ 953 $ — $ 40,666 Special Mention — — — — — — — — Substandard — — — — — — — — Total $ 25,502 $ 2,260 $ 1,985 $ 6,258 $ 3,708 $ 953 $ — $ 40,666 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Commercial Equipment Pass $ 11,833 $ 13,361 $ 6,536 $ 12,185 $ 30,638 $ 4,426 $ — $ 78,979 Special Mention 165 — — — — — — 165 Substandard — 124 — — 28 — — 152 Total $ 11,998 $ 13,485 $ 6,536 $ 12,185 $ 30,666 $ 4,426 $ — $ 79,296 Current Period Gross Write-off $ (21) $ — $ — $ — $ — $ — $ — $ (21) Term Loans by Origination Year (dollars in thousands) Prior 2019 2020 2021 2022 2023 Revolving Loans Total Total loans by risk category $ 496,881 $ 150,358 $ 237,337 $ 357,132 $ 440,875 $ 50,789 $ — $ 1,733,372 Loans evaluated by performance category are as follows: Term Loans by Origination Year (dollars in thousands) Prior 2019 2020 2021 2022 2023 Revolving Loans Total Residential First Mortgages Performing $ 39,629 $ 19,273 $ 8,465 $ 5,178 $ 5,641 $ — $ — $ 78,186 Non-performing — — — — — — — — Total $ 39,629 $ 19,273 $ 8,465 $ 5,178 $ 5,641 $ — $ — $ 78,186 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Home Equity and Second Mortgages Performing $ 15,259 $ 1,012 $ 1,244 $ 3,599 $ 3,729 $ 205 $ — $ 25,048 Non-performing 444 — — — — — — 444 Total $ 15,703 $ 1,012 $ 1,244 $ 3,599 $ 3,729 $ 205 $ — $ 25,492 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Consumer Loans Performing $ 46 $ 69 $ 101 $ 573 $ 774 $ 271 $ 5,437 $ 7,271 Non-performing — — — — Total $ 46 $ 69 $ 101 $ 573 $ 774 $ 271 $ 5,437 $ 7,271 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ (44) $ (44) Total loans evaluated by performing status $ 55,378 $ 20,354 $ 9,810 $ 9,350 $ 10,144 $ 476 $ 5,437 $ 110,949 Total Recorded Investment $ 552,259 $ 170,712 $ 247,147 $ 366,482 $ 451,019 $ 51,265 $ 5,437 $ 1,844,321 Credit quality indicators as of December 31, 2022 were as follows: Credit Risk Profile by Internally Assigned Grade The risk category of loans by class of loans is as follows: Term Loans by Origination Year (dollars in thousands) Prior 2018 2019 2020 2021 2022 Revolving Loans Total Commercial Real Estate Pass $ 329,575 $ 73,742 $ 107,264 $ 184,263 $ 272,567 $ 256,622 $ — $ 1,224,033 Special Mention — 4,191 — — — — — 4,191 Substandard 792 — 2,967 — 843 — — 4,602 Total $ 330,367 $ 77,933 $ 110,231 $ 184,263 $ 273,410 $ 256,622 $ — $ 1,232,826 Residential Rentals Pass $ 44,257 $ 4,429 $ 20,690 $ 48,237 $ 65,889 $ 153,648 $ — $ 337,150 Special Mention — — — — — — — — Substandard 1,142 — — — — — — 1,142 Total $ 45,399 $ 4,429 $ 20,690 $ 48,237 $ 65,889 $ 153,648 $ — $ 338,292 Construction and Land Development Pass $ 2,355 $ 7,788 $ 4,255 $ 729 $ 2,020 $ 112 $ — $ 17,259 Special Mention — — — — — — — — Substandard — — — — — — — — Total $ 2,355 $ 7,788 $ 4,255 $ 729 $ 2,020 $ 112 $ — $ 17,259 Commercial Loans Pass $ 23,225 $ 4,298 $ 2,463 $ 1,872 $ 6,420 $ 3,777 $ — $ 42,055 Special Mention — — — — — — — — Substandard — — — — — — — — Total $ 23,225 $ 4,298 $ 2,463 $ 1,872 $ 6,420 $ 3,777 $ — $ 42,055 Commercial Equipment Pass $ 8,206 $ 4,411 $ 14,329 $ 7,346 $ 12,948 $ 31,315 $ — $ 78,555 Special Mention — 170 — — — — — 170 Substandard — — 137 — — 28 — 165 Total $ 8,206 $ 4,581 $ 14,466 $ 7,346 $ 12,948 $ 31,343 $ — $ 78,890 Total loans by risk category $ 409,552 $ 99,029 $ 152,105 $ 242,447 $ 360,687 $ 445,502 $ — $ 1,709,322 Loans evaluated by performance category are as follows: Term Loans by Origination Year (dollars in thousands) Prior 2018 2019 2020 2021 2022 Revolving Loans Total Residential First Mortgages Performing $ 37,428 $ 3,584 $ 19,411 $ 8,523 $ 5,235 $ 5,691 $ — $ 79,872 Non-performing — — — — — — — — Total $ 37,428 $ 3,584 $ 19,411 $ 8,523 $ 5,235 $ 5,691 $ — $ 79,872 Home Equity and Second Mortgages Performing $ 14,319 $ 1,622 $ 1,041 $ 1,441 $ 3,812 $ 3,161 $ — $ 25,396 Non-performing 206 — — — — — — 206 Total $ 14,525 $ 1,622 $ 1,041 $ 1,441 $ 3,812 $ 3,161 $ — $ 25,602 Consumer Loans Performing $ 49 $ 2 $ 96 $ 118 $ 618 $ 881 $ 4,508 $ 6,272 Non-performing — — — — — — — — Total $ 49 $ 2 $ 96 $ 118 $ 618 $ 881 $ 4,508 $ 6,272 U.S. SBA PPP Loans Performing $ — $ — $ — $ — $ 339 $ — $ — $ 339 Non-performing — — — — — — — — Total $ — $ — $ — $ — $ 339 $ — $ — $ 339 Total loans evaluated by performing status $ 52,002 $ 5,208 $ 20,548 $ 10,082 $ 10,004 $ 9,733 $ 4,508 $ 112,085 Total Recorded Investment $ 461,554 $ 104,237 $ 172,653 $ 252,529 $ 370,691 $ 455,235 $ 4,508 $ 1,821,407 A risk-grading scale is used to assign grades to commercial relationships, which include commercial real estate, residential rentals, construction and land development, commercial loans and commercial equipment loans. Loans are graded at inception, annually thereafter when financial statements are received and at other times when there is an indication that a credit may have weakened or improved. At December 31, 2020 and prior, only commercial loan relationships with an aggregate exposure to the Bank of $1,000,000 or greater were subject to being risk rated. During the quarter ended March 31, 2021, the Bank's policy was amended to risk rate all commercial loan relationships. Home equity and second mortgages and consumer loans are evaluated for creditworthiness in underwriting and are monitored based on borrower payment history. Residential first mortgages are evaluated for creditworthiness during credit due diligence before being purchased. Residential first mortgages, home equity and second mortgages and consumer loans are classified as unrated unless they are part of a larger commercial relationship that requires grading or are BEFD modifications or nonperforming loans with an Other Assets Especially Mentioned ("OAEM") or higher risk rating due to a delinquency payment history. The overall quality of the Bank’s loan portfolio is assessed using the Bank’s risk-grading scale, the level and trends of net charge-offs, nonperforming loans and delinquencies, the performance of BEFD modifications and the general economic conditions in the Company’s geographical market. This review process is assisted by frequent internal reporting of loan production, loan quality, concentrations of credit, loan delinquencies and nonperforming and potential problem loans. Credit quality indicators and allowance factors are adjusted based on management’s judgment during the monthly and quarterly review process. Loans subject to risk ratings are graded on a scale of one to ten. The Company considers loans rated substandard, doubtful and loss as classified assets for regulatory and financial reporting. Ratings 1 thru 6 - Pass Ratings 1 thru 6 have asset risks ranging from excellent-low to adequate. The specific rating assigned considers customer history of earnings, cash flows, liquidity, leverage, capitalization, consistency of debt service coverage, the nature and extent of customer relationship and other relevant specific business factors such as the stability of the industry or market area, changes to management, litigation or unexpected events that could have an impact on risks. Rating 7 - OAEM (Other Assets Especially Mentioned) – Special Mention These credits, while protected by the financial strength of the borrowers, guarantors or collateral, have reduced quality due to economic conditions, less than adequate earnings performance or other factors which require the lending officer to direct more than normal attention to the credit. Financing alternatives may be limited and/or command higher risk interest rates. OAEM loans relationships are reviewed at least quarterly. Rating 8 - Substandard Substandard assets are assets that are inadequately protected by the sound worth or paying capacity of the borrower or of the collateral pledged. Substandard loans are the first adversely classified loans on the Bank's watchlist. These assets have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They are characterized by the possibility that the Bank will sustain some loss if the deficiencies are not corrected. Loss potential, while existing in the aggregate amount of substandard assets, does not have to exist in individual assets classified substandard. The loans may have a delinquent history or combination of weak collateral, weak guarantor strength or operating losses. When a loan is assigned to this category the Bank may estimate a specific reserve in the loan loss allowance analysis. These assets listed may include assets with histories of repossessions or some that are non-performing bankruptcies. These relationships will be reviewed at least quarterly. Rating 9 - Doubtful Doubtful assets have many of the same characteristics of Substandard with the exception that the Bank has determined that loss is not only possible but is probable and the risk is close to certain that loss will occur. When a loan is assigned to this category the Bank will identify the probable loss and the loan will receive a specific reserve in the loan loss allowance analysis. These relationships will be reviewed at least quarterly. Rating 10 – Loss Once an asset is identified as a definite loss to the Bank, it will receive the classification of “loss.” There may be some future potential recovery; however, it is more practical to write off the loan at the time of classification. Losses will be taken in the period in which they are determined to be non-collectable. BEFD modifications included in the individually assessed loan schedules above, as of March 31, 2023 and December 31, 2022 were as follows: March 31, 2023 December 31, 2022 (dollars in thousands) Number of Loans Recorded Investments Number of Loans Recorded Investments Commercial equipment 1 $ 27 2 $ 457 Total BEFD modifications (1) 1 $ 27 2 $ 457 Less: BEFD modifications included in non-accrual loans 1 27 1 28 Total accrual BEFD modifications loans — $ — 1 $ 429 ___________________________________________ (1) On January 1, 2023, the Company adopted ASU 2022-02 – Financial Instruments-Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures, which eliminated the TDR recognition and measurement guidance. As such, loans designated as TDRs prior to January 1, 2023 and are currently performing are no longer reported as a BEFD loan in the quarter ending March 31, 2023, while prior period amounts continue to be reported in accordance with previously applicable GAAP. The Company had a $27,000 specific reserve on one BEFD modification at March 31, 2023 and had a $28,000 specific reserve for one BEFD of $28,000 at December 31, 2022. During the year ended December 31, 2022, there were no BEFD modifications disposals, which included payoffs and refinancing. BEFD modification loan principal curtailment was $1,000 for the three months ended March 31, 2023, and $18,000 for the year ended December 31, 2022. There were no BEFD modifications added during the three months ended March 31, 2023, and one BEFD of $28,000 added during the year ended December 31, 2022. At March 31, 2023, the BEFD modification was current for all principal and interest payments. |
Goodwill and Other Intangible A
Goodwill and Other Intangible Assets | 3 Months Ended |
Mar. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Other Intangible Assets | GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill and other intangible assets are presented in the tables below. (dollars in thousands) As of March 31, 2023 As of December 31, 2022 Goodwill $ 10,835 $ 10,835 As of March 31, 2023 As of December 31, 2022 (dollars in thousands) Gross Carrying Amount Accumulated Amortization Net Intangible Assets Gross Carrying Amount Accumulated Amortization Net Intangible Assets Core deposit intangible ("CDI") $ 3,590 $ (3,040) $ 550 $ 3,590 $ (2,956) $ 634 The estimated aggregate future amortization expense for intangible assets remaining as of March 31, 2023 is as follows: (dollars in thousands) Remainder of 2023 $ 217 2024 205 2025 109 2026 19 2027 — $ 550 At March 31, 2023 the Company had goodwill of $10.8 million or 5.45% of equity and CDI of $0.6 million or 0.28% of equity. Management performed its annual analysis of goodwill and CDI during the fourth quarter of 2022 and concluded that there was no impairment at December 31, 2022. At March 31, 2023, management's analysis concluded that there were no changes in the Company's financial statements or operations subsequent to the fourth quarter 2022 annual analysis that would indicate that it was more likely than not that goodwill or CDI was impaired. |
Other Real Estate Owned ("OREO"
Other Real Estate Owned ("OREO") | 3 Months Ended |
Mar. 31, 2023 | |
Real Estate [Abstract] | |
Other Real Estate Owned ("OREO") | OTHER REAL ESTATE OWNED (“OREO”) OREO assets are presented net of the valuation allowance. The Company considers OREO as classified assets for regulatory and financial reporting. OREO carrying amounts reflect management’s estimate of the realizable value of these properties incorporating current appraised values, local real estate market conditions and related costs. The Company had no OREO at March 31, 2023 and December 31, 2022. There were no expenses applicable to OREO assets at March 31, 2023 and December 31, 2022. The Company had $89,000 in loans secured by residential real estate for which formal foreclosure proceedings were in process as of March 31, 2023. There were no loans secured by residential real estate for which formal foreclosure proceedings were in the process as of December 31, 2022. |
Deposits
Deposits | 3 Months Ended |
Mar. 31, 2023 | |
Deposits, by Type [Abstract] | |
Deposits | DEPOSITS Deposits consist of the following: March 31, 2023 December 31, 2022 (dollars in thousands) Balance % Balance % Noninterest-bearing demand $ 599,763 27.84 % $ 630,120 30.17 % Interest-bearing: Demand 697,312 32.37 % 638,876 30.59 % Money market deposits 305,329 14.17 % 347,872 16.66 % Savings 121,007 5.62 % 124,533 5.96 % Certificates of deposit 430,912 20.00 % 347,062 16.62 % Total interest-bearing 1,554,560 72.16 % 1,458,343 69.83 % Total Deposits $ 2,154,323 100.00 % $ 2,088,463 100.00 % The aggregate amount of certificates of deposit that exceed the FDIC insurance limit of $250,000 at March 31, 2023 and December 31, 2022 was $193.3 million and $114.7 million, respectively. At March 31, 2023 the scheduled contractual maturities of certificates of deposit are as follows: (dollars in thousands) March 31, 2023 Within one year $ 288,627 Year 2 87,400 Year 3 39,196 Year 4 4,470 Year 5 11,219 $ 430,912 The Company monitors all customer deposit concentrations at or above 2% of total deposits. At March 31, 2023, the Bank had two customer deposit relationships that exceeded 2% of total deposits, totaling $320.9 million which represented 14.9% of total deposits. At December 31, 2022, the Bank had two customer deposit relationships that exceeded 2% of total deposits, totaling $346.4 million which represented 16.6% of total deposits. These concentrations were with local municipal agencies. |
Lease Commitments & Contingenci
Lease Commitments & Contingencies | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Lease Commitments & Contingencies | LEASE COMMITMENTS & CONTINGENCIES Operating Leases The Company's, operating lease agreements are primarily for leases of branches and office space. Topic 842 requires operating lease agreements to be recognized on the consolidated balance sheet as a right-of-use-asset with a corresponding lease liability. The table below details the Right of Use asset (net of accumulated amortization), lease liability and other information related to the Company's operating leases: (dollars in thousands) March 31, 2023 December 31, 2022 Operating Leases Operating lease right of use asset, net $ 5,817 $ 5,920 Operating lease liability $ 6,114 $ 6,202 Weighted average remaining lease term 15.5 years 15.7 years Weighted average discount rate 3.51 % 3.51 % Remaining lease term - min 4.3 years 4.5 years Remaining lease term - max 21.0 years 22.0 years The table below details the Company's lease cost, which is included in occupancy expense in the Unaudited Consolidated Statements of Income. Three Months Ended March 31, (dollars in thousands) 2023 2022 Operating lease cost $ 158 $ 146 Cash paid for lease liability $ 142 $ 131 A maturity analysis of operating lease liabilities and reconciliation of the undiscounted cash flows to the total operating lease liability is as follows: (dollars in thousands) As of March 31, 2023 Lease payments due: Within one year $ 578 After one but within two years 590 After two but within three years 631 After three but within four years 640 After four but within five years 589 After five years 5,095 Total undiscounted cash flows $ 8,123 Discount on cash flows 2,009 Total lease liability $ 6,114 |
Lease Commitments & Contingencies | LEASE COMMITMENTS & CONTINGENCIES Operating Leases The Company's, operating lease agreements are primarily for leases of branches and office space. Topic 842 requires operating lease agreements to be recognized on the consolidated balance sheet as a right-of-use-asset with a corresponding lease liability. The table below details the Right of Use asset (net of accumulated amortization), lease liability and other information related to the Company's operating leases: (dollars in thousands) March 31, 2023 December 31, 2022 Operating Leases Operating lease right of use asset, net $ 5,817 $ 5,920 Operating lease liability $ 6,114 $ 6,202 Weighted average remaining lease term 15.5 years 15.7 years Weighted average discount rate 3.51 % 3.51 % Remaining lease term - min 4.3 years 4.5 years Remaining lease term - max 21.0 years 22.0 years The table below details the Company's lease cost, which is included in occupancy expense in the Unaudited Consolidated Statements of Income. Three Months Ended March 31, (dollars in thousands) 2023 2022 Operating lease cost $ 158 $ 146 Cash paid for lease liability $ 142 $ 131 A maturity analysis of operating lease liabilities and reconciliation of the undiscounted cash flows to the total operating lease liability is as follows: (dollars in thousands) As of March 31, 2023 Lease payments due: Within one year $ 578 After one but within two years 590 After two but within three years 631 After three but within four years 640 After four but within five years 589 After five years 5,095 Total undiscounted cash flows $ 8,123 Discount on cash flows 2,009 Total lease liability $ 6,114 |
Guaranteed Preferred Beneficial
Guaranteed Preferred Beneficial Interest in Junior Subordinated Debentures ("TRUPs") | 3 Months Ended |
Mar. 31, 2023 | |
Guaranteed Preferred Beneficial Interest in Junior Subordinated Debentures (TRUPs) [Abstract] | |
Guaranteed Preferred Beneficial Interest in Junior Subordinated Debentures ("TRUPs") | GUARANTEED PREFERRED BENEFICIAL INTEREST IN JUNIOR SUBORDINATED DEBENTURES (“TRUPs”) On June 15, 2005, Tri-County Capital Trust II (“Capital Trust II”), a Delaware business trust formed, funded and wholly-owned by the Company, issued $5.0 million of variable-rate capital securities in a private pooled transaction. The variable rate is based on the 90-day LIBOR rate plus 1.70%. The Trust used the proceeds from this issuance, along with the $0.2 million for Capital Trust II’s common securities, to purchase $5.2 million of the Company’s junior subordinated debentures. The interest rate on the debentures and the trust preferred securities is variable and adjusts quarterly. These capital securities qualify as Tier I capital and are presented in the Consolidated Balance Sheets as “Guaranteed Preferred Beneficial Interests in Junior Subordinated Debentures.” Both the capital securities of Capital Trust II and the junior subordinated debentures are scheduled to mature on June 15, 2035, unless called by the Company. On July 22, 2004, Tri-County Capital Trust I (“Capital Trust I”), a Delaware business trust formed, funded and wholly owned by the Company, issued $7.0 million of variable-rate capital securities in a private pooled transaction. The variable rate is based on the 90-day LIBOR rate plus 2.60%. The Trust used the proceeds from this issuance, along with the Company’s $0.2 million capital contribution for Capital Trust I’s common securities, to purchase $7.2 million of the Company’s junior subordinated debentures. The interest rate on the debentures and the trust preferred securities is variable and adjusts quarterly. These debentures qualify as Tier I capital and are presented in the Consolidated Balance Sheets as “Guaranteed Preferred Beneficial Interests in Junior Subordinated Debentures.” Both the capital securities of Capital Trust I and the junior subordinated debentures are scheduled to mature on July 22, 2034, unless called by the Company. As both the Capital Trust I and Capital Trust II variable-rate capital securities are LIBOR-linked instruments that mature after June 30, 2023, the interest rate will transition from a LIBOR-based rate to an alternative reference rate. Both instruments are subject to the Adjustable Interest Rate (LIBOR) Act (the “LIBOR Act”) and neither instrument contains a fallback provision or a clearly defined or practicable fallback provision in the event that LIBOR is no longer published or quoted. The interest rate on both the Capital Trust I and Capital Trust II will transition pursuant to the LIBOR Act to a rate based on the Secured Overnight Financing Rate (“SOFR”) after June 30, 2023. |
Subordinated Notes
Subordinated Notes | 3 Months Ended |
Mar. 31, 2023 | |
Subordinated Borrowings [Abstract] | |
Subordinated Notes | SUBORDINATED NOTESOn October 14, 2020, the Company issued and sold $20.0 million in aggregate principal amount of its 4.75% Fixed to Floating Rate Subordinated Notes due 2030 (the "Notes"). The Notes were sold by the Company in a private offering. The Notes mature on October 15, 2030 and bear interest at a fixed rate of 4.75% to October 14, 2025. From October 15, 2025 to the maturity date or early redemption date, the interest rate will reset quarterly to the three-month Secured Overnight Financing Rate ("SOFR") plus 458 basis points. The Company may redeem the Notes at any time after October 14, 2025, and at any time in whole, but not in part, upon the occurrence of certain events. Any redemption of the Notes will be subject to prior regulatory approval. The Company incurred debt issuance costs for placement fees, legal and other out-of-pocket expenses of approximately $0.6 million, which are being amortized over the life of the Notes. The Company recognized amortization expense of $14,000 and $14,000 for the three months ended March 31, 2023 and 2022, respectively. |
Regulatory Capital
Regulatory Capital | 3 Months Ended |
Mar. 31, 2023 | |
Regulatory Assets and Liabilities Disclosure [Abstract] | |
Regulatory Capital | REGULATORY CAPITAL The Bank’s primary federal regulator is the Federal Deposit Insurance Corporation (“FDIC”). The Bank is subject to regulation, supervision and regular examination by the Maryland Commissioner of Financial Regulation (the “Commissioner”) and the FDIC. The Company is subject to regulation, examination and supervision by the Federal Reserve Board under the Bank Holding Company Act of 1956, as amended (the “BHCA”). The Company and Bank are subject to the Basel III Capital Rules which establish a comprehensive capital framework for U.S. banking organizations. The rules implement the Basel Committee’s “Basel III” framework for strengthening international capital standards as well as certain provisions of the Dodd-Frank Act. The Basel III Capital Rules define the components of capital and address other issues affecting the numerator in banking institutions’ regulatory capital ratios. The Basel III Capital Rules also address risk weights and other issues affecting the denominator in banking institutions’ regulatory capital ratios. The rules include a common equity Tier 1 capital to risk-weighted assets minimum ratio of 4.50%, a minimum ratio of Tier 1 capital to risk-weighted assets of 6.0%, require a minimum ratio (“Min. Ratio”) of Total Capital to risk-weighted assets of 8.0%, and require a minimum Tier 1 leverage ratio of 4.0%. A capital conservation buffer (“CCB”) is also established above the regulatory minimum capital requirements. The rules revised the definition and calculation of Tier 1 capital, Total Capital, and risk-weighted assets. As of March 31, 2023 and December 31, 2022, the Company and Bank were well-capitalized under the regulatory framework for prompt corrective action ("PCA") under the new Basel III Capital Rules. Management believes, as of March 31, 2023 and December 31, 2022, that the Company and the Bank met all capital adequacy requirements to which they were subject. The Company’s and the Bank’s actual regulatory capital amounts and ratios are presented in the following table. Regulatory Capital and Ratios Regulatory Minimum Ratio + CCB (1) The Company The Bank (dollars in thousands) March 31, 2023 December 31, 2022 March 31, 2023 December 31, 2022 Common equity $ 198,806 $ 187,011 $ 227,967 $ 216,408 Goodwill (10,835) (10,835) (10,835) (10,835) Core deposit intangible (net of deferred tax liability) (414) (477) (414) (477) AOCI losses 37,896 43,092 37,896 43,092 Common Equity Tier 1 Capital 225,453 218,791 254,614 248,188 TRUPs 12,000 12,000 — — Tier 1 Capital 237,453 230,791 254,614 248,188 Allowable reserve for credit losses and other Tier 2 adjustments 23,911 23,303 23,911 23,303 Subordinated notes 19,580 19,566 — — Tier 2 Capital $ 280,944 $ 273,660 $ 278,525 $ 271,491 Risk-Weighted Assets ("RWA") $ 1,956,402 $ 1,943,516 $ 1,954,574 $ 1,941,922 Average Assets ("AA") $ 2,453,436 $ 2,404,643 $ 2,451,758 $ 2,403,268 Common Tier 1 Capital to RWA 7.00% 11.52 % 11.26 % 13.03 % 12.78 % Tier 1 Capital to RWA 8.50% 12.14 11.87 13.03 12.78 Tier 2 Capital to RWA 10.50% 14.36 14.08 14.25 13.98 Tier 1 Capital to AA (Leverage) (2) n/a 9.68 9.60 10.38 10.33 ___________________________________________ (1) The regulatory minimum capital ratio ("Min. Ratio") + the capital conservation buffer ("CCB"). (2) Tier 1 Capital to AA (Leverage) has no capital conservation buffer defined. The PCA well capitalized is defined as 5.00%. Dividends paid by the Company are substantially funded from dividends received from the Bank. Federal and holding company regulations, as well as Maryland law, impose certain restrictions on capital distributions, including dividend payments and share repurchases. These restrictions generally require advanced approval from the Bank's regulator for payment of dividends in excess of the sum of net income for the current calendar year and the retained net income of the prior two calendar years. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | FAIR VALUE MEASUREMENTS The Company adopted FASB ASC Topic 820, “Fair Value Measurements” and FASB ASC Topic 825, “The Fair Value Option for Financial Assets and Financial Liabilities” , which provides a framework for measuring and disclosing fair value under U.S. GAAP. FASB ASC Topic 820 requires disclosures about the fair value of assets and liabilities recognized in the balance sheet in periods subsequent to initial recognition, whether the measurements are made on a recurring basis (for example, AFS investment securities) or on a nonrecurring basis (for example, individually evaluated loans). FASB ASC Topic 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. FASB ASC Topic 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company utilizes fair value measurements to record fair value adjustments to certain assets and to determine fair value disclosures. AFS securities are recorded at fair value on a recurring basis. Additionally, from time to time, the Company may be required to record at fair value other assets on a nonrecurring basis such as loans held for investment and certain other assets. These nonrecurring fair value adjustments typically involve application of lower of cost or market accounting or write-downs of individual assets. Under FASB ASC Topic 820, the Company groups assets and liabilities at fair value in three levels, based on the markets in which the assets and liabilities are traded, and the reliability of the assumptions used to determine the fair value. These hierarchy levels are: Level 1 inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that the entity has the ability to access at the measurement date. Level 2 inputs - Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets and liabilities in active markets, and inputs other than quoted prices that are observable for the asset or liability, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs - Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity’s own assumptions about the assumptions that market participants would use in pricing the assets or liabilities. Transfers between levels of the fair value hierarchy are recognized on the actual date of the event or circumstances that caused the transfer, which generally coincides with the Company’s quarterly valuation process. Intra-quarter transfers in and out of level 3 assets and liabilities recorded at fair value on a recurring basis are disclosed. There were no such transfers during the quarter ended March 31, 2023 or the year ended December 31, 2022. Following is a description of valuation methodologies used for assets and liabilities recorded at fair value: Securities Available for Sale AFS investment securities are recorded at fair value on a recurring basis. Standard inputs include quoted prices, if available. If quoted prices are not available, fair values are measured using independent pricing models or other model-based valuation techniques such as the present value of future cash flows, adjusted for the security’s credit rating, prepayment assumptions and other factors such as credit loss assumptions. Level 1 securities include those traded on an active exchange, such as the New York Stock Exchange, Treasury securities that are traded by dealers or brokers in active over-the-counter markets and money market funds. Level 2 securities include mortgage-backed securities issued by government sponsored entities (“GSEs”), municipal bonds and corporate debt securities. Securities classified as Level 3 include asset-backed securities in less liquid markets. Equity Securities Carried at Fair Value Through Income Equity securities carried at fair value through income are recorded at fair value on a recurring basis. Standard inputs include quoted prices, if available. If quoted prices are not available, fair values are measured using independent pricing models or other model-based valuation techniques such as the present value of future cash flows, adjusted for the security’s credit rating, prepayment assumptions and other factors such as credit loss assumptions. Level 1 equity securities include those traded on an active exchange, such as the New York Stock Exchange. Level 2 equity securities include mutual funds with asset-backed securities issued by government sponsored entities (“GSEs”) as the underlying investment supporting the fund. Equity securities classified as Level 3 include mutual funds with asset-backed securities in less liquid markets. Loans Receivable The Company does not record loans at fair value on a recurring basis; however, from time to time, a loan is individually evaluated and an ACL is established. Loans for which it is probable that payment of interest and principal will not be made in accordance with the contractual terms of the loan are segregated individually. Management estimates the fair value of individually evaluated loans using one of several methods, including the collateral value, market value of similar debt, or discounted cash flows. Individually evaluated loans not requiring an allowance are those for which the fair value of expected repayments or collateral exceed the recorded investment in such loans. At March 31, 2023 and December 31, 2022, substantially all of the individually evaluated loans were based upon the fair value of the collateral. In accordance with FASB ASC 820, loans where an allowance is established based on the fair value of collateral (loans with impairment) require classification in the fair value hierarchy. When the fair value of the collateral is based on an observable market price (e.g., contracted sales price), the Company records the loan as nonrecurring Level 2. When the fair value of the impaired loan is derived from an appraisal, the Company records the loan as nonrecurring Level 3. Fair value is re-assessed at least quarterly or more frequently when circumstances occur that indicate a change in the fair value. The fair values of impaired loans that are not measured based on collateral values are measured using discounted cash flows and considered to be Level 3 inputs. Other Real Estate Owned ("OREO") OREO is adjusted for fair value upon transfer of the loans to foreclosed assets. Subsequently, OREO is reported at the lower of carrying value or fair value. Fair value is based on independent market prices, appraised value of the collateral or management’s estimation of the value of the collateral. When the fair value of the collateral is based on an observable market price (e.g., contracted sales price), the Company records the foreclosed asset as nonrecurring Level 2. When the fair value is derived from an appraisal, the Company records the foreclosed asset at nonrecurring Level 3. Assets and Liabilities Recorded at Fair Value on a Recurring Basis The tables below present the recorded amount of assets as of March 31, 2023 and December 31, 2022 measured at fair value on a recurring basis. (dollars in thousands) March 31, 2023 Description of Asset Fair Value Level 1 Level 2 Level 3 AFS securities Asset-backed securities issued by GSEs and U.S. Agencies MBS $ 114,031 $ — $ 114,031 $ — CMOs 158,728 — 158,728 — U.S. Agency 12,685 — 12,685 — Asset-backed securities issued by Others: Residential CMOs 11,999 — 11,999 — Student Loan Trust ABSs 44,934 — 44,934 — Municipal bonds 82,892 — 82,892 — Corporate bonds 4,363 — 4,363 — U.S. government obligations 34,317 — 34,317 — Total AFS securities $ 463,949 $ — $ 463,949 $ — Equity securities carried at fair value through income CRA investment fund $ 4,380 $ — $ 4,380 $ — Non-marketable equity securities Other equity securities $ 207 $ — $ 207 $ — (dollars in thousands) December 31, 2022 Description of Asset Fair Value Level 1 Level 2 Level 3 AFS securities Asset-backed securities issued by GSEs and U.S. Agencies MBS $ 113,670 $ — $ 113,670 $ — CMOs 159,413 — 159,413 — U.S. Agency 12,356 — 12,356 — Asset-backed securities issued by others: Residential CMOs 12,206 — 12,206 — Student Loan Trust ABSs 47,312 — 47,312 — Municipal bonds 79,618 — 79,618 — U.S. government obligations 33,767 — 33,767 — Total AFS securities $ 462,746 $ — $ 462,746 $ — Equity securities carried at fair value through income CRA investment fund $ 4,286 $ — $ 4,286 $ — Non-marketable equity securities Other equity securities $ 207 $ — $ 207 $ — Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis The Company may be required to measure certain assets at fair value on a nonrecurring basis in accordance with U.S. GAAP. These include assets that are measured at the lower of cost or market that were recognized at fair value below cost at the end of the period. Loans with an allowance had unpaid principal balances of $1.4 million and $0.1 million at March 31, 2023 and December 31, 2022, respectively. The fair value of individually assessed loans with an allowance measured on a non-recurring basis was zero as of December 31, 2022. Assets measured at fair value on a nonrecurring basis as of March 31, 2023 are included in the tables below. (dollars in thousands) March 31, 2023 Description of Asset Fair Value Level 1 Level 2 Level 3 Individually assessed loans with an allowances Commercial real estate $ 948 $ — $ — $ 948 Commercial loans — — — — Commercial equipment — — — — Total individually assessed loans with an allowances $ 948 $ — $ — $ 948 The following tables provide information describing the unobservable inputs used in Level 3 fair value measurements at March 31, 2023. There were no Level 3 recurring assets or liabilities at December 31, 2022. March 31, 2023 Fair Value Valuation Technique Unobservable Inputs Range (Weighted Average) (dollars in thousands) Description of Asset Individually assessed loans with an allowances $ 948 Third party appraisals and in-house equipment evaluations of fair value Management discount for equipment type and current market conditions 0% - 50% - 100% |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 3 Months Ended |
Mar. 31, 2023 | |
Investments, All Other Investments [Abstract] | |
Fair Value of Financial Instruments | FAIR VALUE OF FINANCIAL INSTRUMENTS Financial instruments require disclosure of fair value information, whether or not recognized in the consolidated balance sheets, when it is practical to estimate the fair value. A financial instrument is defined as cash, evidence of an ownership interest in an entity or a contractual obligation which requires the exchange of cash. Certain items are specifically excluded from the financial instrument fair value disclosure requirements, including the Company’s common stock, OREO, premises and equipment and other assets and liabilities. The estimated fair value amounts have been determined by the Company using available market information and appropriate valuation methodologies. However, considerable judgment is required to interpret market data to develop the estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts. Therefore, any aggregate unrealized gains or losses should not be interpreted as a forecast of future earnings or cash flows. Furthermore, the fair values disclosed should not be interpreted as the aggregate current value of the Company. The Company’s estimated fair values of financial instruments are presented in the following tables. March 31, 2023 Carrying Amount Fair Value Fair Value Measurements Description of Asset (dollars in thousands) Level 1 Level 2 Level 3 Assets Investment securities - AFS $ 463,949 $ 463,949 $ — $ 463,949 $ — Equity securities carried at fair value through income 4,380 4,380 — 4,380 — Non-marketable equity securities in other financial institutions 207 207 — 207 — FHLB Stock 2,181 2,181 — 2,181 — Net loans receivable 1,820,806 1,759,458 — — 1,759,458 Accrued interest receivable 8,526 8,526 — 8,526 — Investment in BOLI 40,019 40,019 — 40,019 — Liabilities Savings, NOW and money market accounts $ 1,723,411 $ 1,723,411 $ — $ 1,723,411 $ — Time deposits 430,912 431,741 — 431,741 — Short-term borrowings 21,500 21,595 — 21,595 — TRUPs 12,000 9,740 — 9,740 — Subordinated notes 19,580 18,753 — 18,753 — See the Company’s methodologies disclosed in Note 21 of the Company’s 2022 Form 10-K for the fair value methodologies used as of December 31, 2022: December 31, 2022 Carrying Amount Fair Value Fair Value Measurements Description of Asset (dollars in thousands) Level 1 Level 2 Level 3 Assets Investment securities - AFS $ 462,746 $ 462,746 $ — $ 462,746 $ — Equity securities carried at fair value through income 4,286 4,286 — 4,286 — Non-marketable equity securities in other financial institutions 207 207 — 207 — FHLB Stock 4,584 4,584 — 4,584 — Net loans receivable 1,798,517 1,743,574 — — 1,743,574 Accrued interest receivable 8,335 8,335 — 8,335 — Investment in BOLI 39,802 39,802 — 39,802 — Liabilities Savings, NOW and money market accounts $ 1,741,401 $ 1,741,401 $ — $ 1,741,401 $ — Time deposits 347,062 346,261 — 346,261 — Short-term borrowings 79,000 79,087 — 79,087 — TRUPs 12,000 10,296 — 10,296 — Subordinated notes 19,566 18,745 — 18,745 — At March 31, 2023 and December 31, 2022, the Company had outstanding loan commitments and standby letters of credit with customers of $47.0 million and $44.9 million, respectively, and $22.0 million and $25.0 million, respectively. Additionally, at March 31, 2023 and December 31, 2022, customers had $276.1 million and $278.1 million, respectively, available and unused on lines of credit, which include lines of credit for commercial customers, home equity loans as well as builder and construction lines. Based on the short-term lives of these instruments, the Company does not believe that the fair value of these instruments differs significantly from their carrying values. The fair value estimates presented herein are based on pertinent information available to management as of March 31, 2023 and December 31, 2022. Although management is not aware of any factors that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for purposes of these Consolidated Financial Statements since that date and, therefore, current estimates of fair value may differ significantly from the amounts presented herein. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income/Loss ("AOCI/"AOCL") | 3 Months Ended |
Mar. 31, 2023 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Accumulated Other Comprehensive Income/Loss ("AOCI/"AOCL") | ACCUMULATED OTHER COMPREHENSIVE INCOME/LOSS ("AOCI"/"AOCL") The following table presents the changes in each component of accumulated other comprehensive gain, net of tax, for the three months ended March 31, 2023 and 2022. Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 (dollars in thousands) Net Unrealized Gains And Losses Net Unrealized Gains And Losses Beginning of period $ (43,092) $ (1,952) Other comprehensive gains ( losses), net of tax before reclassifications 5,196 (17,017) Net other comprehensive gains (losses) 5,196 (17,017) End of period $ (37,896) $ (18,969) |
Earnings Per Share ("EPS")
Earnings Per Share ("EPS") | 3 Months Ended |
Mar. 31, 2023 | |
Earnings Per Share [Abstract] | |
Earnings Per Share ("EPS") | EARNINGS PER SHARE (“EPS”) Basic earnings per common share represent income available to common shareholders, divided by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflect additional common shares that would have been outstanding if dilutive potential common shares had been issued. Potential common shares that may have been issued by the Company related to outstanding unvested restricted stock unit and performance stock unit awards were determined using the treasury stock method and included in the calculation of dilutive common stock equivalents. The Company has not granted any stock options since 2007 and all outstanding options expired on July 17, 2017. As of the three months ended March 31, 2023, and 2022, there were 1,854 and zero, respectively of unvested restricted stock and performance stock unit awards which were excluded from the calculation as their effect would be anti-dilutive. Basic and diluted earnings per share have been computed based on weighted-average common and common equivalent shares outstanding as follows: (dollars in thousands, except per share amounts) Three Months Ended March 31, 2023 2022 Net Income $ 7,327 $ 6,288 Average number of common shares outstanding 5,651,750 5,688,221 Dilutive effect of common stock equivalents 3,832 10,817 Average number of shares used to calculate diluted EPS 5,655,582 5,699,038 Anti-dilutive shares 1,854 — Earnings Per Common Share Basic $ 1.30 $ 1.11 Diluted $ 1.30 $ 1.10 |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | INCOME TAXES The Company files a consolidated federal income tax return with its subsidiaries. Deferred tax assets and liabilities are determined using the liability (or balance sheet) method which requires that deferred tax assets and liabilities be recognized using enacted tax rates for the effect of temporary differences between the book and tax bases of recorded assets and liabilities. If it is more likely than not that some portion or the entire deferred tax asset will not be realized, deferred tax assets will be reduced by a valuation allowance. It is the Company’s policy to recognize accrued interest and penalties related to unrecognized tax benefits as a component of tax expense. (dollars in thousands) Three Months Ended March 31, 2023 2022 Current income tax expense $ 2,375 $ 1,927 Deferred income tax (benefit) expense (7) 206 Income tax expense as reported $ 2,368 $ 2,133 Effective tax rate 24.4 % 25.3 % Net deferred tax assets totaled $21.9 million at March 31, 2023 and $24.7 million at December 31, 2022. No valuation allowance for deferred tax assets was recorded at March 31, 2023 as management believes it is more likely than not that deferred tax assets will be realized against deferred tax liabilities and projected future taxable income. The effective tax rate differed from the statutory federal and state income rates during 2023 and 2022 primarily due to the effect of tax-exempt loans, life insurance policies, the income tax effects associated with stock-based compensation and certain non-deductible expenses for state income taxes. The Company’s consolidated effective tax rate is expected to be between 24.50% and 26.00% in 2023. |
Basis of Presentation and Nat_2
Basis of Presentation and Nature of Operations (Policies) | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The Consolidated Financial Statements include the accounts of The Community Financial Corporation and its wholly-owned subsidiary, Community Bank of the Chesapeake (the “Bank”), (collectively, the “Company”), included herein are unaudited. The Consolidated Financial Statements reflect all adjustments consisting only of normal recurring accruals that, in the opinion of management, are necessary to present fairly the Company’s financial condition, results of operations, and cash flows for the periods presented. Certain information and note disclosures normally included in Consolidated Financial Statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to the rules and regulations of the SEC. Management believes that the included disclosures are adequate to make the information presented not misleading. The balances as of December 31, 2022 have been derived from audited Consolidated Financial Statements. The Company’s accounting policies are disclosed in Note 1 to the 2022 Consolidated Financial Statements. The results of operations for the three months March 31, 2023 are not necessarily indicative of the results of operations to be expected for the remainder of the year or any other period. These Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes included in the Company’s 2022 Annual Report on Form 10-K. |
Reclassification | ReclassificationCertain items in prior Consolidated Financial Statements have been reclassified to conform to the current presentation. |
Nature of Operations | Nature of Operations The Company provides financial services to individuals and businesses through its offices in Southern Maryland and Fredericksburg, Virginia. Its primary deposit products are demand, savings and time deposits, and its primary lending products are commercial and residential mortgage loans, commercial loans, construction and land development loans, home equity and second mortgages and commercial equipment loans. |
Use of Estimates | Use of Estimates The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the Consolidated Financial Statements and the reported amount of income and expenses during the reporting periods. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for credit losses ("ACL"), real estate acquired in the settlement of loans ("OREO"), fair value of financial instruments, fair value of assets acquired, and liabilities assumed in a business combination, evaluating potential credit losses of investment securities and valuation of deferred tax assets. |
Loans | Loans Loans that the Company has the intent and ability to hold for the foreseeable future, or until maturity or payoff, are reported at their outstanding unpaid principal balances, adjusted for the allowance for credit losses and any deferred fees or premiums. Interest income is accrued on the unpaid principal balance. Loan origination fees and premiums, net of certain direct origination costs, are deferred and recognized as an adjustment of the related loan yield using the interest method. Loans purchased with evidence of credit deterioration since origination and for which it is probable that all contractually required payments will not be collected are considered credit deteriorated. Evidence of credit quality deterioration as of the purchase date may include statistics such as internal risk grade, past due and nonaccrual status, recent borrower credit scores and recent loan-to-value (“LTV”) percentages. The Company considers a loan to be past due or delinquent when the terms of the contractual obligation are not met by the borrower. Loans are reviewed on a regular basis and are placed on non-accrual status when, in the opinion of management, the collection of additional interest is doubtful. The accrual of interest on mortgage and commercial loans is discontinued at the time the loan is 90 days delinquent unless the credit is well secured and in the process of collection. Non-accrual loans include certain loans that are current with all loan payments and are placed on non-accrual status due to customer operating results and cash flows. Non-accrual loans are evaluated for impairment on a loan-by-loan basis in accordance with the Company’s impairment methodology. Consumer loans, excluding credit card loans, are typically charged-off no later than 90 days past due. Credit card loans are typically charged-off no later than 180 days past due. Mortgage and commercial loans are fully or partially charged-off when in management’s judgment all reasonable efforts to return a loan to performing status have occurred. In all cases, loans are placed on non-accrual or charged-off at an earlier date if collection of principal or interest is considered doubtful. All interest accrued but not collected from loans that are placed on non-accrual or charged-off is reversed against interest income. The interest on these loans is accounted for on the cash-basis or cost-recovery method, until qualifying for return to accrual status. Loans are returned to accrual status when all principal and interest amounts contractually due are brought current and future payments are reasonably assured. Modifications to borrowers experiencing financial difficulty (BEFD) are loans that have been modified to provide for a reduction or a delay in the payment of either interest or principal because of deterioration in the financial condition of the borrower. A loan extended or renewed at a stated interest rate equal to the current interest rate for new debt with similar risk is not considered a BEFD modification. Once an obligation has been classified as a BEFD modification it continues to be considered a BEFD modification until paid in full or until the debt is refinanced and considered unimpaired. All BEFD modifications are assessed on a loan-by-loan basis. The Company does not participate in any specific government or Company-sponsored loan modification programs. All restructured loan agreements are individual contracts negotiated with a borrower. |
Allowance for Credit Losses - Loans, AFS Debt securities, Collateral Dependent Financial Assets and Loan Commitments and Allowance for Credit Losses on Off-Balance Sheet Credit Exposure | Allowance for Credit Losses - Loans The ACL is an estimate of the expected credit losses for loans held for investment and off-balance sheet exposures. Accounting Standards Codification ("ASC") 326, "Financial Instruments-Credit Losses" requires an immediate recognition of the credit loss expected to occur over the lifetime of a financial asset whether originated or purchased. Charge-offs are recorded to the ACL when management believes the loan is uncollectible. Subsequent recoveries, if any, are credited to the ACL. Management believes the ACL is in accordance with U.S. GAAP and in compliance with appropriate regulatory guidelines. The ACL includes quantitative estimates of losses for collectively and individually evaluated loans. As more fully described below, the model-based quantitative estimate for collectively evaluated loans is determined using the probability of default ("PD") and loss given default ("LGD") at the segment level and applied at the loan level against the expected exposure at default ("EAD"). Qualitative adjustments to the quantitative estimate may be made using information not considered in the quantitative model. The Bank uses a range of data to estimate expected credit losses under CECL, including information about past events, current conditions, and reasonable and supportable forecasts relevant to assessing the collectability of the cash flows of the loans. Historical loss experience serves as the foundation for our estimated credit losses. Adjustments to our historical loss experience are made for differences in current loan portfolio segment credit risk characteristics such as the impact of changing unemployment rates, changes in U.S. Treasury yields, portfolio concentrations, the volume of classified loans, inflation, and other prevailing economic conditions and factors that may affect the borrower’s ability to repay, or reduce the estimated value of underlying collateral. This evaluation is inherently subjective, as it requires estimates that are susceptible to significant revision as more information becomes available. The ACL is measured on a collective basis when similar risk characteristics exist. Generally, collectively assessed loans are grouped by loan type code or product type codes and assigned to a corresponding portfolio segment. Portfolio segments may be further subdivided into similar risk profile groupings based on interest rate structure, types of collateral or other terms and characteristics. The probability of default (“PD”) calculation analyzes the historical loan portfolio over the given look back period to identify, by segment, loans that have defaulted. A default is defined as a loan that has moved to past due 90 days and greater, nonaccrual status, or experienced a charge-off during the period. The model observes loans over a 12-month window, detecting any events previously defined. This information is then used by the model to calculate annual iterative count-based PD rates for each segment. This process is then repeated for all dates within the historical data range. These averaged PD’s are used for a 12-month straight-line reversion to the historical mean. The historical data used was from mid-2006 through the most recent quarter end. The Company utilizes reasonable and supportable forecasts of future economic conditions when estimating the ACL on loans. The model’s calculation also includes a 12-month forecasted PD based on a regression model that compares the Company’s historical loan data to various national economic metrics during the same periods. The results show the Company’s past losses having a high rate of correlation to national unemployment rates for fixed rate loans and the 10-Year U.S. Treasury for adjustable-rate loans. The model uses this information, along with the most recently published Wall Street Journal survey of sixty economists’ forecasts predicting unemployment rates out over the next four quarters to estimate the PD for the forward-looking 12-month period. These data are also used to predict credit losses at different levels of stress, including a baseline, low, high and adverse economic conditions. After the forecast period, PD rates revert to the historical mean straight line over a 12-month period for the entire data set. The loss given default (“LGD”) calculation is based on actual losses (charge-offs, net of recoveries) at a loan level over the entire look-back period aggregated for each loan segment. The aggregate loss is divided by the exposure at default to determine an LGD rate. Defaults occurring during the look-back period are included in the denominator, whether or not a loss occurred and exposure at default is determined by the loan balance immediately preceding the default event. When the Company's data are insufficient. an industry index is used. The exposure at default (“EAD”) calculation projects future expected balances from monthly cash flow schedules to apply PD and LGD assumptions. These are derived based on current contractual terms (balance, interest rate, payment structure), adjusted for expected voluntary prepayments. The contractual terms exclude expected extensions, renewals and modifications unless either of the following applies: management has the reasonable expectation that a loan will be restructured, or the extension or renewal option are included in the borrower contract. On a quarterly basis, the Company uses internal portfolio credit data, such as levels of non-accrual loans, classified assets and concentrations of credit along with other external information not used in the quantitative calculation to determine qualitative adjustments. Loans that do not share the same common risk characteristics with other loans are individually assessed. Such loans include non-accrual loans, BEFD modifications, loans classified as substandard or worse, loans that are greater than 89 days delinquent and any other loan identified by management for individual assessment. Reserves on individually assessed loans are measured on a loan-by-loan basis. Generally, consumer loans, including credit cards, are not individually assessed as the Bank's policy is to charge-off credit card loans when they become 180 days delinquent and other consumer loans when they are more than 90 days delinquent. The methodology used to estimate the ACL is designed to be responsive to changes in portfolio credit quality and forecasted economic conditions. Changes due to new information are reflected in the pool-based allowance and in reserves assigned on an individual basis. Executive management closely monitors loss ratios, reviews the appropriateness of the ACL and presents conclusions to the Credit Risk Committee and the Audit Committee. The committees report to the Board as part of Board's quarterly review of our regulatory reporting and consolidated financial statements. The calculation of the ACL excludes accrued interest receivable balances because these balances are reversed in a timely manner against previously recognized interest income when a loan is placed on non-accrual status. Allowance for Credit Losses - AFS Debt securities The Company does not presently hold any HTM debt securities and therefore is not presently required to apply a CECL methodology for an HTM investment portfolio. The impairment model for AFS debt securities measures fair value. Although ASU No. 2016-13 replaced the legacy other-than-temporary impairment (“OTTI”) model with a credit loss model, it retained the fundamental nature of the legacy OTTI model for AFS securities. One notable change from the legacy OTTI model is when evaluating whether credit loss exists, an entity may no longer consider the length of time fair value has been less than amortized cost. For AFS debt securities in an unrealized loss position, the Company first assesses whether it intends to sell, or it is more likely than not that it will be required to sell the security before recovery of its amortized cost basis. If either criterion is met, the security’s amortized cost basis is written down to fair value through income. For AFS debt securities that do not meet the aforementioned criteria, the Company evaluates whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, management considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and a corresponding allowance for credit losses is recorded. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income. Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit losses. Losses are charged against the allowance when management believes the uncollectibility of an AFS security is confirmed or when either of the criteria regarding intent or requirement to sell is met. Any impairment not recorded through an allowance for credit loss is recognized in other comprehensive income as a noncredit-related impairment. As of March 31, 2023, the Company determined that the unrealized loss positions in AFS securities were not the result of credit losses, and therefore, an allowance for credit losses was not recorded. See Note 2 Investment Securities for more information. The Bank elected to exclude accrued interest from the amortized cost basis of AFS debt securities and report accrued interest separately in accrued interest and other assets in the consolidated balance sheets. AFS debt securities are placed on non-accrual status when management no longer expects to receive all contractual amounts due, which is generally at 90 days past due. Accrued interest receivable is reversed against interest income when a security is placed on non-accrual status. Accordingly, the Company does not recognize an allowance for credit loss against accrued interest receivable. The majority of AFS debt securities as of March 31, 2023 and December 31, 2022 were issued by Government Sponsored Enterprises (“GSEs”) and U.S. agencies. As such, an allowance for credit losses is not considered necessary. Collateral Dependent Financial Assets Loans that do not share risk characteristics are evaluated on an individual basis. For collateral dependent financial assets where the Company has determined that foreclosure of the collateral is probable, or where the borrower is experiencing financial difficulty and the Company expects repayment of the financial asset to be provided substantially through the operation or sale of the collateral, the ACL is measured based on the difference between the fair value of the collateral and the amortized cost basis of the asset as of the measurement date. When repayment is expected to be from the operation of the collateral, expected credit losses are calculated as the amount by which the amortized cost basis of the financial asset exceeds the Net Present Value ("NPV") from the operation of the collateral. When repayment is expected to be from the sale of the collateral, expected credit losses are calculated as the amount by which the amortized costs basis of the financial asset exceeds the fair value of the underlying collateral less estimated cost to sell. The ACL may be zero if the fair value of the collateral at the measurement date exceeds the amortized cost basis of the financial asset. Subsequent changes to the fair value of collateral, for which an ACL was previously recognized, will be reported as a provision (recovery) for credit losses. The Bank generally uses the practical expedient of the fair value of the collateral, net of estimated selling costs, to determine the expected credit loss for individually assessed collateral dependent loans. Loan Commitments and Allowance for Credit Losses on Off-Balance Sheet Credit Exposure Financial instruments include off-balance sheet credit instruments such as commitments to make loans and commercial letters of credit issued to meet customer financing needs. The Company's exposure to credit loss in the event of nonperformance by the other party to the financial instrument for off-balance sheet loan commitments is represented by the contractual amount of those instruments. Such financial instruments are recorded when they are funded. The Company records a reserve for unfunded commitments (“RUC”) on off-balance sheet credit exposures through a charge to provision for credit loss expense in the Company’s consolidated statements of operations. The RUC on off-balance sheet credit exposures is estimated by loan segment at each balance sheet date under the CECL model using the same methodologies as portfolio loans, taking into consideration the likelihood that funding will occur, and is included in Other Liabilities on the Company’s consolidated balance sheets. See Note 1 – Summary of Significant Accounting Policies included in the Company’s 2022 Annual Report on Form 10-K for a list of policies in effect as of December 31, 2022. |
Adopted New Accounting Standard | Adopted New Accounting Standard ASU 2020-04 – Reference Rate Reform (Topic 848 ). In March 2020, the FASB issued guidance to provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. The amendments are effective as of March 12, 2020 through December 31, 2024, as deferred under ASU 2022-06 - Reference Rate Reform (Topic 848) Deferral of the Sunset Date of Topic 848. The amendments did not have a material effect on its Consolidated Financial Statements. ASU Update 2022-02 – On January 1, 2023, the Company adopted ASU 2022-02 – Financial Instruments-Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures. ASU 2022-02 eliminates the TDRs recognition and measurement guidance and, instead requires that an entity evaluate whether the modification represents a new loan or a continuation of an existing loan. The amendments enhance existing disclosure requirements and introduce new requirements related to certain modifications of receivables made to borrowers experiencing financial difficulty. In addition, ASU Update 2022-02 requires that an entity disclose current-period gross write-offs by year of origination for financing receivables and net investment in leases. The Company adopted ASU 2022-02 using a modified retrospective transition method for TDRs. The impact of adoption was immaterial. The disclosure amendments in the Update 2022-02 will be applied prospectively. |
Investment Securities (Tables)
Investment Securities (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of Amortized Cost and Fair Values of Investment Securities | Amortized cost and fair values of investment securities at March 31, 2023 and December 31, 2022 are summarized as follows: March 31, 2023 (dollars in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value AFS Securities Asset-backed securities issued by GSEs and U.S. Agencies Residential Mortgage Backed Securities ("MBS") $ 125,680 $ 11 $ 11,660 $ 114,031 Residential Collateralized Mortgage Obligations ("CMOs") 173,344 7 14,623 158,728 U.S. Agency 14,714 — 2,029 12,685 Asset-backed securities ("ABSs") issued by Others: Residential CMOs 12,369 3 373 11,999 Student Loan Trust ABSs 46,771 29 1,866 44,934 Municipal bonds 99,686 — 16,794 82,892 Corporate bonds 4,867 — 504 4,363 U.S. government obligations 36,851 1 2,535 34,317 Total AFS Securities $ 514,282 $ 51 $ 50,384 $ 463,949 Equity securities carried at fair value through income CRA investment fund $ 4,380 $ — $ — $ 4,380 Non-marketable equity securities Other equity securities $ 207 $ — $ — $ 207 Total Investment Securities $ 518,869 $ 51 $ 50,384 $ 468,536 December 31, 2022 (dollars in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value AFS Securities Asset-backed securities issued by GSEs and U.S. Agencies Residential MBS $ 126,861 $ 12 $ 13,203 $ 113,670 Residential CMOs 175,905 8 16,500 159,413 U.S. Agency 14,658 — 2,302 12,356 Asset-backed securities issued by Others: Residential CMOs 12,593 13 400 12,206 Student Loan Trust ABSs 49,566 39 2,293 47,312 Municipal bonds 99,766 — 20,148 79,618 Corporate bonds 4,863 — 459 4,404 U.S. government obligations 36,813 1 3,047 33,767 Total AFS Securities $ 521,025 $ 73 $ 58,352 $ 462,746 Equity securities carried at fair value through income CRA investment fund $ 4,286 $ — $ — $ 4,286 Non-marketable equity securities Other equity securities $ 207 $ — $ — $ 207 Total Investment Securities $ 525,518 $ 73 $ 58,352 $ 467,239 |
Schedule of Unrealized Losses and Estimated Fair Value | AFS Securities Gross unrealized losses and estimated fair value by length of time that individual AFS securities have been in a continuous unrealized loss position at March 31, 2023 and December 31, 2022 were as follows: March 31, 2023 Less Than 12 Months More Than 12 Months Total (dollars in thousands) Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Losses Asset-backed securities issued by GSEs and U.S. Agencies $ 9,383 $ 543 $ 273,811 $ 27,769 $ 283,194 $ 28,312 Asset-backed securities issued by Others 10,266 353 129 20 10,395 373 Student Loan Trust ABSs — — 40,076 1,866 40,076 1,866 Municipal bonds 1,107 10 81,785 16,784 82,892 16,794 Corporate bonds 1,861 6 2,502 498 4,363 504 U.S. government obligations — — 32,333 2,535 32,333 2,535 $ 22,617 $ 912 $ 430,636 $ 49,472 $ 453,253 $ 50,384 December 31, 2022 Less Than 12 Months More Than 12 Months Total (dollars in thousands) Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Losses Asset-backed securities issued by GSEs and U.S. Agencies $ 24,688 $ 1,493 $ 259,127 $ 30,512 $ 283,815 $ 32,005 Asset-backed securities issued by Others 7,469 381 138 19 7,607 400 Student Loan Trust ABSs 1,950 1 42,170 2,292 44,120 2,293 Municipal bonds 6,695 796 72,923 19,352 79,618 20,148 Corporate bonds 4,404 459 — — 4,404 459 U.S. government obligations 18,764 1,137 13,041 1,910 31,805 3,047 $ 63,970 $ 4,267 $ 387,399 $ 54,085 $ 451,369 $ 58,352 |
Schedule of Amortized Cost and Fair Values of Debt Securities | The amortized cost and estimated fair value of debt securities at March 31, 2023 and December 31, 2022 by contractual maturity, are shown below. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call premiums or prepayment penalties. March 31, 2023 December 31, 2022 (dollars in thousands) Amortized Cost Estimated Fair Value Amortized Cost Estimated Fair Value Within one year $ 37,444 $ 33,780 $ 35,441 $ 31,477 Over one year through five years 132,267 119,322 136,449 121,186 Over five years through ten years 224,597 202,615 228,997 203,383 After ten years 119,974 108,232 120,138 106,700 Total AFS securities $ 514,282 $ 463,949 $ 521,025 $ 462,746 |
Loans (Tables)
Loans (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Receivables [Abstract] | |
Schedule of Loans Receivable | Portfolio loans, net of deferred costs and fees, are summarized by type as follows at March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 (dollars in thousands) Total % of Total Loans Total % of Total Loans Portfolio Loans: Commercial real estate $ 1,265,519 68.63 % $ 1,232,826 67.69 % Residential first mortgages 78,186 4.24 % 79,872 4.39 % Residential rentals 329,417 17.86 % 338,292 18.58 % Construction and land development 18,474 1.00 % 17,259 0.95 % Home equity and second mortgages 25,492 1.38 % 25,602 1.41 % Commercial loans 40,666 2.20 % 42,055 2.31 % Consumer loans 7,271 0.39 % 6,272 0.34 % Commercial equipment 79,296 4.30 % 78,890 4.33 % Total portfolio loans (1) 1,844,321 100.00 % 1,821,068 100.00 % Less: Allowance for Credit Losses (23,515) (1.27) % (22,890) (1.26) % Total net portfolio loans 1,820,806 1,798,178 U.S. SBA PPP loans (1) — 339 Total net loans $ 1,820,806 $ 1,798,517 ___________________________________________ (1) Excludes accrued interest receivable of $6.8 million and $6.6 million, at March 31, 2023 and December 31, 2022, respectively. |
Non-accrual Loans | Non-accrual loans as of March 31, 2023 and December 31, 2022 were as follows: March 31, 2023 (dollars in thousands) Nonaccrual with No Allowance for Credit Losses Nonaccrual with Allowance for Credit Losses Total Nonaccrual Loans Commercial real estate $ 4,498 $ 1,391 $ 5,889 Residential rentals 1,631 — 1,631 Home equity and second mortgages 444 — 444 Consumer loans — 9 9 Commercial equipment 124 27 151 Total $ 6,697 $ 1,427 $ 8,124 Interest Income on Nonaccrual Loans $ 63 $ — $ 63 December 31, 2022 (dollars in thousands) Nonaccrual with No Allowance for Credit Losses Nonaccrual with Allowance for Credit Losses Total Nonaccrual Loans Commercial real estate $ 4,521 $ 81 $ 4,602 Residential rentals 1,142 — 1,142 Home equity and second mortgages 206 — 206 Commercial equipment 137 28 165 Total $ 6,006 $ 109 $ 6,115 Interest Income on Nonaccrual Loans $ 121 $ — $ 121 March 31, 2023 (dollars in thousands) Non-accrual Delinquent Loans Non-accrual Current Loans Total Non-accrual Loans Commercial real estate $ — $ 5,889 $ 5,889 Residential rentals 274 1,357 1,631 Home equity and second mortgages 444 — 444 Consumer loans 9 — 9 Commercial equipment — 151 151 $ 727 $ 7,397 $ 8,124 December 31, 2022 (dollars in thousands) Non-accrual Delinquent Loans Non-accrual Current Loans Total Non-accrual Loans Commercial real estate $ — $ 4,602 $ 4,602 Residential first mortgages — — — Residential rentals 449 693 1,142 Home equity and second mortgages 206 — 206 Commercial equipment — 165 165 U.S. SBA PPP loans — — — $ 655 $ 5,460 $ 6,115 The following table presents the amortized cost basis of collateral-dependent loans by class of loans. March 31, 2023 December 31, 2022 (dollars in thousands) Business/Other Assets Real Estate Business/Other Assets Real Estate Commercial real estate $ — $ 5,889 $ — $ 4,601 Residential rentals — 1,631 — 1,142 Home equity and second mortgages — 444 — 206 Consumer loans 9 — — — Commercial equipment 151 — 595 — Total $ 160 $ 7,964 $ 595 $ 5,949 |
Past Due Financing Receivables | An analysis of days past due ("DPD") loans as of March 31, 2023 follows: March 31, 2023 (dollars in thousands) 31-60 DPD 61-89 DPD 90 DPD and Still Accruing 90 DPD and Not Accruing Total Past Due Current Non-Accrual Loans Current Accrual Loans Total Loans Commercial real estate $ 525 $ — $ — $ — $ 525 $ 5,889 $ 1,259,105 $ 1,265,519 Residential first mortgages — — — — — — 78,186 78,186 Residential rentals — — — 274 274 1,357 327,786 329,417 Construction and land development — — — — — — 18,474 18,474 Home equity and second mortgages 263 70 — 205 538 — 24,954 25,492 Commercial loans — — — — — — 40,666 40,666 Consumer loans 66 30 35 — 131 — 7,140 7,271 Commercial equipment — — — — — 151 79,145 79,296 Total Loans $ 854 $ 100 $ 35 $ 479 $ 1,468 $ 7,397 $ 1,835,456 $ 1,844,321 Loan delinquency (total past due) increased $0.4 million from $1.0 million, or 0.06% of loans, at December 31, 2022 to $1.5 million, or 0.08% of loans, at March 31, 2023. An analysis of days past due loans as of December 31, 2022 follows: December 31, 2022 (dollars in thousands) 31-60 DPD 61-89 DPD 90 DPD and Still Accruing 90 DPD and Not Accruing Total Past Due Current Non-Accrual Loans Current Accrual Loans Total Loans Commercial real estate $ 147 $ — $ — $ — $ 147 $ 4,602 $ 1,228,077 $ 1,232,826 Residential first mortgages — — — — — — 79,872 79,872 Residential rentals — 177 — 272 449 693 337,150 338,292 Construction and land development — — — — — — 17,259 17,259 Home equity and second mortgages 53 160 — 116 329 — 25,273 25,602 Commercial loans — — — — — — 42,055 42,055 Consumer loans 21 35 50 — 106 — 6,166 6,272 Commercial equipment 11 — — — 11 165 78,714 78,890 U.S. SBA PPP loans — — — — — — 339 339 Total portfolio loans $ 232 $ 372 $ 50 $ 388 $ 1,042 $ 5,460 $ 1,814,905 $ 1,821,407 |
Allowance for Credit Losses on Financing Receivables | The following tables detail activity in the ACL at and for the three months ended March 31, 2023 and 2022. An allocation of the allowance to one category of loans does not prevent the Company from using that allowance to absorb losses in a different category. Three Months Ended March 31, 2023 (dollars in thousands) Beginning Balance Charge-offs Recoveries Provisions Ending Balance Commercial real estate $ 17,650 $ — $ 16 $ 726 $ 18,392 Residential first mortgages 207 — — (4) 203 Residential rentals 3,061 — — (156) 2,905 Construction and land development 160 — — 1 161 Home equity and second mortgages 126 — — 5 131 Commercial loans 190 — — 14 204 Consumer loans 154 (44) — 56 166 Commercial equipment 1,342 (21) 4 28 1,353 $ 22,890 $ (65) $ 20 $ 670 $ 23,515 Three Months Ended March 31, 2022 (dollars in thousands) Beginning Balance Impact of ASC 326 Adoption Charge-offs Recoveries Provisions Ending Balance Commercial real estate $ 13,095 $ 3,734 $ — $ — $ 484 $ 17,313 Residential first mortgages 1,002 (679) — — (39) 284 Residential rentals 2,175 (586) — — (43) 1,546 Construction and land development 260 (82) — — (41) 137 Home equity and second mortgages 274 (86) — — (10) 178 Commercial loans 582 (290) — 1 26 319 Consumer loans 58 2 — — 13 73 Commercial equipment 971 483 — 18 60 1,532 $ 18,417 $ 2,496 $ — $ 19 $ 450 $ 21,382 |
Credit Quality Indicators | Credit quality indicators as of March 31, 2023 were as follows: Credit Risk Profile by Internally Assigned Grade The risk category of loans by class of loans is as follows: Term Loans by Origination Year (dollars in thousands) Prior 2019 2020 2021 2022 2023 Revolving Loans Total Commercial Real Estate Pass $ 393,557 $ 108,531 $ 175,180 $ 261,755 $ 287,060 $ 23,827 $ — $ 1,249,910 Special Mention 4,167 — 5,553 — — — — 9,720 Substandard 2,088 2,960 — 841 — — — 5,889 Total $ 399,812 $ 111,491 $ 180,733 $ 262,596 $ 287,060 $ 23,827 $ — $ 1,265,519 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Residential Rentals Pass $ 46,757 $ 20,527 $ 47,452 $ 72,733 $ 119,293 $ 21,024 $ — $ 327,786 Special Mention — — — — — — — — Substandard 1,631 — — — — — — 1,631 Total $ 48,388 $ 20,527 $ 47,452 $ 72,733 $ 119,293 $ 21,024 $ — $ 329,417 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Construction and Land Development Pass $ 11,181 $ 2,595 $ 631 $ 3,360 $ 148 $ 559 $ — $ 18,474 Special Mention — — — — — — — — Substandard — — — — — — — — Total $ 11,181 $ 2,595 $ 631 $ 3,360 $ 148 $ 559 $ — $ 18,474 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Commercial Loans Pass $ 25,502 $ 2,260 $ 1,985 $ 6,258 $ 3,708 $ 953 $ — $ 40,666 Special Mention — — — — — — — — Substandard — — — — — — — — Total $ 25,502 $ 2,260 $ 1,985 $ 6,258 $ 3,708 $ 953 $ — $ 40,666 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Commercial Equipment Pass $ 11,833 $ 13,361 $ 6,536 $ 12,185 $ 30,638 $ 4,426 $ — $ 78,979 Special Mention 165 — — — — — — 165 Substandard — 124 — — 28 — — 152 Total $ 11,998 $ 13,485 $ 6,536 $ 12,185 $ 30,666 $ 4,426 $ — $ 79,296 Current Period Gross Write-off $ (21) $ — $ — $ — $ — $ — $ — $ (21) Term Loans by Origination Year (dollars in thousands) Prior 2019 2020 2021 2022 2023 Revolving Loans Total Total loans by risk category $ 496,881 $ 150,358 $ 237,337 $ 357,132 $ 440,875 $ 50,789 $ — $ 1,733,372 Loans evaluated by performance category are as follows: Term Loans by Origination Year (dollars in thousands) Prior 2019 2020 2021 2022 2023 Revolving Loans Total Residential First Mortgages Performing $ 39,629 $ 19,273 $ 8,465 $ 5,178 $ 5,641 $ — $ — $ 78,186 Non-performing — — — — — — — — Total $ 39,629 $ 19,273 $ 8,465 $ 5,178 $ 5,641 $ — $ — $ 78,186 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Home Equity and Second Mortgages Performing $ 15,259 $ 1,012 $ 1,244 $ 3,599 $ 3,729 $ 205 $ — $ 25,048 Non-performing 444 — — — — — — 444 Total $ 15,703 $ 1,012 $ 1,244 $ 3,599 $ 3,729 $ 205 $ — $ 25,492 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ — $ — Consumer Loans Performing $ 46 $ 69 $ 101 $ 573 $ 774 $ 271 $ 5,437 $ 7,271 Non-performing — — — — Total $ 46 $ 69 $ 101 $ 573 $ 774 $ 271 $ 5,437 $ 7,271 Current Period Gross Write-off $ — $ — $ — $ — $ — $ — $ (44) $ (44) Total loans evaluated by performing status $ 55,378 $ 20,354 $ 9,810 $ 9,350 $ 10,144 $ 476 $ 5,437 $ 110,949 Total Recorded Investment $ 552,259 $ 170,712 $ 247,147 $ 366,482 $ 451,019 $ 51,265 $ 5,437 $ 1,844,321 Credit quality indicators as of December 31, 2022 were as follows: Credit Risk Profile by Internally Assigned Grade The risk category of loans by class of loans is as follows: Term Loans by Origination Year (dollars in thousands) Prior 2018 2019 2020 2021 2022 Revolving Loans Total Commercial Real Estate Pass $ 329,575 $ 73,742 $ 107,264 $ 184,263 $ 272,567 $ 256,622 $ — $ 1,224,033 Special Mention — 4,191 — — — — — 4,191 Substandard 792 — 2,967 — 843 — — 4,602 Total $ 330,367 $ 77,933 $ 110,231 $ 184,263 $ 273,410 $ 256,622 $ — $ 1,232,826 Residential Rentals Pass $ 44,257 $ 4,429 $ 20,690 $ 48,237 $ 65,889 $ 153,648 $ — $ 337,150 Special Mention — — — — — — — — Substandard 1,142 — — — — — — 1,142 Total $ 45,399 $ 4,429 $ 20,690 $ 48,237 $ 65,889 $ 153,648 $ — $ 338,292 Construction and Land Development Pass $ 2,355 $ 7,788 $ 4,255 $ 729 $ 2,020 $ 112 $ — $ 17,259 Special Mention — — — — — — — — Substandard — — — — — — — — Total $ 2,355 $ 7,788 $ 4,255 $ 729 $ 2,020 $ 112 $ — $ 17,259 Commercial Loans Pass $ 23,225 $ 4,298 $ 2,463 $ 1,872 $ 6,420 $ 3,777 $ — $ 42,055 Special Mention — — — — — — — — Substandard — — — — — — — — Total $ 23,225 $ 4,298 $ 2,463 $ 1,872 $ 6,420 $ 3,777 $ — $ 42,055 Commercial Equipment Pass $ 8,206 $ 4,411 $ 14,329 $ 7,346 $ 12,948 $ 31,315 $ — $ 78,555 Special Mention — 170 — — — — — 170 Substandard — — 137 — — 28 — 165 Total $ 8,206 $ 4,581 $ 14,466 $ 7,346 $ 12,948 $ 31,343 $ — $ 78,890 Total loans by risk category $ 409,552 $ 99,029 $ 152,105 $ 242,447 $ 360,687 $ 445,502 $ — $ 1,709,322 Loans evaluated by performance category are as follows: Term Loans by Origination Year (dollars in thousands) Prior 2018 2019 2020 2021 2022 Revolving Loans Total Residential First Mortgages Performing $ 37,428 $ 3,584 $ 19,411 $ 8,523 $ 5,235 $ 5,691 $ — $ 79,872 Non-performing — — — — — — — — Total $ 37,428 $ 3,584 $ 19,411 $ 8,523 $ 5,235 $ 5,691 $ — $ 79,872 Home Equity and Second Mortgages Performing $ 14,319 $ 1,622 $ 1,041 $ 1,441 $ 3,812 $ 3,161 $ — $ 25,396 Non-performing 206 — — — — — — 206 Total $ 14,525 $ 1,622 $ 1,041 $ 1,441 $ 3,812 $ 3,161 $ — $ 25,602 Consumer Loans Performing $ 49 $ 2 $ 96 $ 118 $ 618 $ 881 $ 4,508 $ 6,272 Non-performing — — — — — — — — Total $ 49 $ 2 $ 96 $ 118 $ 618 $ 881 $ 4,508 $ 6,272 U.S. SBA PPP Loans Performing $ — $ — $ — $ — $ 339 $ — $ — $ 339 Non-performing — — — — — — — — Total $ — $ — $ — $ — $ 339 $ — $ — $ 339 Total loans evaluated by performing status $ 52,002 $ 5,208 $ 20,548 $ 10,082 $ 10,004 $ 9,733 $ 4,508 $ 112,085 Total Recorded Investment $ 461,554 $ 104,237 $ 172,653 $ 252,529 $ 370,691 $ 455,235 $ 4,508 $ 1,821,407 |
TDRs, Included in Impaired Loans Schedule | BEFD modifications included in the individually assessed loan schedules above, as of March 31, 2023 and December 31, 2022 were as follows: March 31, 2023 December 31, 2022 (dollars in thousands) Number of Loans Recorded Investments Number of Loans Recorded Investments Commercial equipment 1 $ 27 2 $ 457 Total BEFD modifications (1) 1 $ 27 2 $ 457 Less: BEFD modifications included in non-accrual loans 1 27 1 28 Total accrual BEFD modifications loans — $ — 1 $ 429 ___________________________________________ (1) On January 1, 2023, the Company adopted ASU 2022-02 – Financial Instruments-Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures, which eliminated the TDR recognition and measurement guidance. As such, loans designated as TDRs prior to January 1, 2023 and are currently performing are no longer reported as a BEFD loan in the quarter ending March 31, 2023, while prior period amounts continue to be reported in accordance with previously applicable GAAP. |
Goodwill and Other Intangible_2
Goodwill and Other Intangible Assets (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of goodwill | Goodwill and other intangible assets are presented in the tables below. (dollars in thousands) As of March 31, 2023 As of December 31, 2022 Goodwill $ 10,835 $ 10,835 |
Schedule of acquired intangible assets | As of March 31, 2023 As of December 31, 2022 (dollars in thousands) Gross Carrying Amount Accumulated Amortization Net Intangible Assets Gross Carrying Amount Accumulated Amortization Net Intangible Assets Core deposit intangible ("CDI") $ 3,590 $ (3,040) $ 550 $ 3,590 $ (2,956) $ 634 |
Schedule of estimated amortization expense | The estimated aggregate future amortization expense for intangible assets remaining as of March 31, 2023 is as follows: (dollars in thousands) Remainder of 2023 $ 217 2024 205 2025 109 2026 19 2027 — $ 550 |
Deposits (Tables)
Deposits (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Deposits, by Type [Abstract] | |
Schedule of Deposits | Deposits consist of the following: March 31, 2023 December 31, 2022 (dollars in thousands) Balance % Balance % Noninterest-bearing demand $ 599,763 27.84 % $ 630,120 30.17 % Interest-bearing: Demand 697,312 32.37 % 638,876 30.59 % Money market deposits 305,329 14.17 % 347,872 16.66 % Savings 121,007 5.62 % 124,533 5.96 % Certificates of deposit 430,912 20.00 % 347,062 16.62 % Total interest-bearing 1,554,560 72.16 % 1,458,343 69.83 % Total Deposits $ 2,154,323 100.00 % $ 2,088,463 100.00 % |
Scheduled of Contractual Maturities of Certificates of Deposit | At March 31, 2023 the scheduled contractual maturities of certificates of deposit are as follows: (dollars in thousands) March 31, 2023 Within one year $ 288,627 Year 2 87,400 Year 3 39,196 Year 4 4,470 Year 5 11,219 $ 430,912 |
Lease Commitments & Contingen_2
Lease Commitments & Contingencies (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Maturities of Operating Lease Liabilities | The table below details the Right of Use asset (net of accumulated amortization), lease liability and other information related to the Company's operating leases: (dollars in thousands) March 31, 2023 December 31, 2022 Operating Leases Operating lease right of use asset, net $ 5,817 $ 5,920 Operating lease liability $ 6,114 $ 6,202 Weighted average remaining lease term 15.5 years 15.7 years Weighted average discount rate 3.51 % 3.51 % Remaining lease term - min 4.3 years 4.5 years Remaining lease term - max 21.0 years 22.0 years A maturity analysis of operating lease liabilities and reconciliation of the undiscounted cash flows to the total operating lease liability is as follows: (dollars in thousands) As of March 31, 2023 Lease payments due: Within one year $ 578 After one but within two years 590 After two but within three years 631 After three but within four years 640 After four but within five years 589 After five years 5,095 Total undiscounted cash flows $ 8,123 Discount on cash flows 2,009 Total lease liability $ 6,114 |
Lease Cost | The table below details the Company's lease cost, which is included in occupancy expense in the Unaudited Consolidated Statements of Income. Three Months Ended March 31, (dollars in thousands) 2023 2022 Operating lease cost $ 158 $ 146 Cash paid for lease liability $ 142 $ 131 |
Regulatory Capital (Tables)
Regulatory Capital (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Regulatory Assets and Liabilities Disclosure [Abstract] | |
Regulatory Matters | The Company’s and the Bank’s actual regulatory capital amounts and ratios are presented in the following table. Regulatory Capital and Ratios Regulatory Minimum Ratio + CCB (1) The Company The Bank (dollars in thousands) March 31, 2023 December 31, 2022 March 31, 2023 December 31, 2022 Common equity $ 198,806 $ 187,011 $ 227,967 $ 216,408 Goodwill (10,835) (10,835) (10,835) (10,835) Core deposit intangible (net of deferred tax liability) (414) (477) (414) (477) AOCI losses 37,896 43,092 37,896 43,092 Common Equity Tier 1 Capital 225,453 218,791 254,614 248,188 TRUPs 12,000 12,000 — — Tier 1 Capital 237,453 230,791 254,614 248,188 Allowable reserve for credit losses and other Tier 2 adjustments 23,911 23,303 23,911 23,303 Subordinated notes 19,580 19,566 — — Tier 2 Capital $ 280,944 $ 273,660 $ 278,525 $ 271,491 Risk-Weighted Assets ("RWA") $ 1,956,402 $ 1,943,516 $ 1,954,574 $ 1,941,922 Average Assets ("AA") $ 2,453,436 $ 2,404,643 $ 2,451,758 $ 2,403,268 Common Tier 1 Capital to RWA 7.00% 11.52 % 11.26 % 13.03 % 12.78 % Tier 1 Capital to RWA 8.50% 12.14 11.87 13.03 12.78 Tier 2 Capital to RWA 10.50% 14.36 14.08 14.25 13.98 Tier 1 Capital to AA (Leverage) (2) n/a 9.68 9.60 10.38 10.33 ___________________________________________ (1) The regulatory minimum capital ratio ("Min. Ratio") + the capital conservation buffer ("CCB"). (2) Tier 1 Capital to AA (Leverage) has no capital conservation buffer defined. The PCA well capitalized is defined as 5.00%. |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value, Assets Measured on Recurring Basis | The tables below present the recorded amount of assets as of March 31, 2023 and December 31, 2022 measured at fair value on a recurring basis. (dollars in thousands) March 31, 2023 Description of Asset Fair Value Level 1 Level 2 Level 3 AFS securities Asset-backed securities issued by GSEs and U.S. Agencies MBS $ 114,031 $ — $ 114,031 $ — CMOs 158,728 — 158,728 — U.S. Agency 12,685 — 12,685 — Asset-backed securities issued by Others: Residential CMOs 11,999 — 11,999 — Student Loan Trust ABSs 44,934 — 44,934 — Municipal bonds 82,892 — 82,892 — Corporate bonds 4,363 — 4,363 — U.S. government obligations 34,317 — 34,317 — Total AFS securities $ 463,949 $ — $ 463,949 $ — Equity securities carried at fair value through income CRA investment fund $ 4,380 $ — $ 4,380 $ — Non-marketable equity securities Other equity securities $ 207 $ — $ 207 $ — (dollars in thousands) December 31, 2022 Description of Asset Fair Value Level 1 Level 2 Level 3 AFS securities Asset-backed securities issued by GSEs and U.S. Agencies MBS $ 113,670 $ — $ 113,670 $ — CMOs 159,413 — 159,413 — U.S. Agency 12,356 — 12,356 — Asset-backed securities issued by others: Residential CMOs 12,206 — 12,206 — Student Loan Trust ABSs 47,312 — 47,312 — Municipal bonds 79,618 — 79,618 — U.S. government obligations 33,767 — 33,767 — Total AFS securities $ 462,746 $ — $ 462,746 $ — Equity securities carried at fair value through income CRA investment fund $ 4,286 $ — $ 4,286 $ — Non-marketable equity securities Other equity securities $ 207 $ — $ 207 $ — |
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis | Assets measured at fair value on a nonrecurring basis as of March 31, 2023 are included in the tables below. (dollars in thousands) March 31, 2023 Description of Asset Fair Value Level 1 Level 2 Level 3 Individually assessed loans with an allowances Commercial real estate $ 948 $ — $ — $ 948 Commercial loans — — — — Commercial equipment — — — — Total individually assessed loans with an allowances $ 948 $ — $ — $ 948 |
Unobservable Inputs Used In Level 3 Fair Value Measurements | The following tables provide information describing the unobservable inputs used in Level 3 fair value measurements at March 31, 2023. There were no Level 3 recurring assets or liabilities at December 31, 2022. March 31, 2023 Fair Value Valuation Technique Unobservable Inputs Range (Weighted Average) (dollars in thousands) Description of Asset Individually assessed loans with an allowances $ 948 Third party appraisals and in-house equipment evaluations of fair value Management discount for equipment type and current market conditions 0% - 50% - 100% |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Investments, All Other Investments [Abstract] | |
Fair Value, by Balance Sheet Grouping | The Company’s estimated fair values of financial instruments are presented in the following tables. March 31, 2023 Carrying Amount Fair Value Fair Value Measurements Description of Asset (dollars in thousands) Level 1 Level 2 Level 3 Assets Investment securities - AFS $ 463,949 $ 463,949 $ — $ 463,949 $ — Equity securities carried at fair value through income 4,380 4,380 — 4,380 — Non-marketable equity securities in other financial institutions 207 207 — 207 — FHLB Stock 2,181 2,181 — 2,181 — Net loans receivable 1,820,806 1,759,458 — — 1,759,458 Accrued interest receivable 8,526 8,526 — 8,526 — Investment in BOLI 40,019 40,019 — 40,019 — Liabilities Savings, NOW and money market accounts $ 1,723,411 $ 1,723,411 $ — $ 1,723,411 $ — Time deposits 430,912 431,741 — 431,741 — Short-term borrowings 21,500 21,595 — 21,595 — TRUPs 12,000 9,740 — 9,740 — Subordinated notes 19,580 18,753 — 18,753 — See the Company’s methodologies disclosed in Note 21 of the Company’s 2022 Form 10-K for the fair value methodologies used as of December 31, 2022: December 31, 2022 Carrying Amount Fair Value Fair Value Measurements Description of Asset (dollars in thousands) Level 1 Level 2 Level 3 Assets Investment securities - AFS $ 462,746 $ 462,746 $ — $ 462,746 $ — Equity securities carried at fair value through income 4,286 4,286 — 4,286 — Non-marketable equity securities in other financial institutions 207 207 — 207 — FHLB Stock 4,584 4,584 — 4,584 — Net loans receivable 1,798,517 1,743,574 — — 1,743,574 Accrued interest receivable 8,335 8,335 — 8,335 — Investment in BOLI 39,802 39,802 — 39,802 — Liabilities Savings, NOW and money market accounts $ 1,741,401 $ 1,741,401 $ — $ 1,741,401 $ — Time deposits 347,062 346,261 — 346,261 — Short-term borrowings 79,000 79,087 — 79,087 — TRUPs 12,000 10,296 — 10,296 — Subordinated notes 19,566 18,745 — 18,745 — |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income/Loss ("AOCI/"AOCL") (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Schedule of Accumulated Other Comprehensive Income (Loss) | The following table presents the changes in each component of accumulated other comprehensive gain, net of tax, for the three months ended March 31, 2023 and 2022. Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 (dollars in thousands) Net Unrealized Gains And Losses Net Unrealized Gains And Losses Beginning of period $ (43,092) $ (1,952) Other comprehensive gains ( losses), net of tax before reclassifications 5,196 (17,017) Net other comprehensive gains (losses) 5,196 (17,017) End of period $ (37,896) $ (18,969) |
Earnings Per Share ("EPS") (Tab
Earnings Per Share ("EPS") (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Basic and Diluted Earnings Per Share | Basic and diluted earnings per share have been computed based on weighted-average common and common equivalent shares outstanding as follows: (dollars in thousands, except per share amounts) Three Months Ended March 31, 2023 2022 Net Income $ 7,327 $ 6,288 Average number of common shares outstanding 5,651,750 5,688,221 Dilutive effect of common stock equivalents 3,832 10,817 Average number of shares used to calculate diluted EPS 5,655,582 5,699,038 Anti-dilutive shares 1,854 — Earnings Per Common Share Basic $ 1.30 $ 1.11 Diluted $ 1.30 $ 1.10 |
Income Taxes (Tables)
Income Taxes (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Current and Deferred Income Tax Expense (Benefit) | (dollars in thousands) Three Months Ended March 31, 2023 2022 Current income tax expense $ 2,375 $ 1,927 Deferred income tax (benefit) expense (7) 206 Income tax expense as reported $ 2,368 $ 2,133 Effective tax rate 24.4 % 25.3 % |
Investment Securities (Fair Val
Investment Securities (Fair Value to Amortized Cost Basis) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Debt and Equity Securities, FV-NI [Line Items] | ||
Amortized Cost | $ 514,282 | $ 521,025 |
Gross Unrealized Gains | 51 | 73 |
Gross Unrealized Losses | 50,384 | 58,352 |
Estimated Fair Value | 463,949 | 462,746 |
CRA investment fund | 4,380 | 4,286 |
Other equity securities | 207 | 207 |
Total investment securities, amortized cost | 518,869 | 525,518 |
Total investment securities, gross unrealized gains | 51 | 73 |
Total investment securities, gross unrealized losses | 50,384 | 58,352 |
Total investment securities, estimated fair value | 468,536 | 467,239 |
Residential Mortgage Backed Securities ("MBS") | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Amortized Cost | 125,680 | 126,861 |
Gross Unrealized Gains | 11 | 12 |
Gross Unrealized Losses | 11,660 | 13,203 |
Estimated Fair Value | 114,031 | 113,670 |
Residential Collateralized Mortgage Obligations ("CMOs") | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Amortized Cost | 173,344 | 175,905 |
Gross Unrealized Gains | 7 | 8 |
Gross Unrealized Losses | 14,623 | 16,500 |
Estimated Fair Value | 158,728 | 159,413 |
U.S. Agency | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Amortized Cost | 14,714 | 14,658 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 2,029 | 2,302 |
Estimated Fair Value | 12,685 | 12,356 |
Residential CMOs | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Amortized Cost | 12,369 | 12,593 |
Gross Unrealized Gains | 3 | 13 |
Gross Unrealized Losses | 373 | 400 |
Estimated Fair Value | 11,999 | 12,206 |
Student Loan Trust ABSs | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Amortized Cost | 46,771 | 49,566 |
Gross Unrealized Gains | 29 | 39 |
Gross Unrealized Losses | 1,866 | 2,293 |
Estimated Fair Value | 44,934 | 47,312 |
Municipal bonds | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Amortized Cost | 99,686 | 99,766 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 16,794 | 20,148 |
Estimated Fair Value | 82,892 | 79,618 |
Corporate bonds | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Amortized Cost | 4,867 | 4,863 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 504 | 459 |
Estimated Fair Value | 4,363 | 4,404 |
U.S. government obligations | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Amortized Cost | 36,851 | 36,813 |
Gross Unrealized Gains | 1 | 1 |
Gross Unrealized Losses | 2,535 | 3,047 |
Estimated Fair Value | 34,317 | 33,767 |
CRA investment fund | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
CRA investment fund | 4,380 | 4,286 |
Other equity securities | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Other equity securities | $ 207 | $ 207 |
Investment Securities (Narrativ
Investment Securities (Narrative) (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
Investments, Debt and Equity Securities [Abstract] | ||
Accrued interest receivable ("AIR") | $ 1.8 | $ 1.8 |
Asset backed securities pledged to secure certain deposits | $ 58.3 | $ 56.4 |
Investment Securities (Schedule
Investment Securities (Schedule of Unrealized Loss on Investments, AFS) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Fair Value | ||
Less than 12 months, fair value | $ 22,617 | $ 63,970 |
More than 12 months, fair value | 430,636 | 387,399 |
Fair value | 453,253 | 451,369 |
Unrealized Loss | ||
Less than 12 months, unrealized loss | 912 | 4,267 |
More than 12 months, unrealized loss | 49,472 | 54,085 |
Unrealized loss | 50,384 | 58,352 |
Asset-backed securities issued by GSEs and U.S. Agencies | ||
Fair Value | ||
Less than 12 months, fair value | 9,383 | 24,688 |
More than 12 months, fair value | 273,811 | 259,127 |
Fair value | 283,194 | 283,815 |
Unrealized Loss | ||
Less than 12 months, unrealized loss | 543 | 1,493 |
More than 12 months, unrealized loss | 27,769 | 30,512 |
Unrealized loss | 28,312 | 32,005 |
Asset-backed securities issued by Others | ||
Fair Value | ||
Less than 12 months, fair value | 10,266 | 7,469 |
More than 12 months, fair value | 129 | 138 |
Fair value | 10,395 | 7,607 |
Unrealized Loss | ||
Less than 12 months, unrealized loss | 353 | 381 |
More than 12 months, unrealized loss | 20 | 19 |
Unrealized loss | 373 | 400 |
Student Loan Trust ABSs | ||
Fair Value | ||
Less than 12 months, fair value | 0 | 1,950 |
More than 12 months, fair value | 40,076 | 42,170 |
Fair value | 40,076 | 44,120 |
Unrealized Loss | ||
Less than 12 months, unrealized loss | 0 | 1 |
More than 12 months, unrealized loss | 1,866 | 2,292 |
Unrealized loss | 1,866 | 2,293 |
Municipal bonds | ||
Fair Value | ||
Less than 12 months, fair value | 1,107 | 6,695 |
More than 12 months, fair value | 81,785 | 72,923 |
Fair value | 82,892 | 79,618 |
Unrealized Loss | ||
Less than 12 months, unrealized loss | 10 | 796 |
More than 12 months, unrealized loss | 16,784 | 19,352 |
Unrealized loss | 16,794 | 20,148 |
Corporate bonds | ||
Fair Value | ||
Less than 12 months, fair value | 1,861 | 4,404 |
More than 12 months, fair value | 2,502 | 0 |
Fair value | 4,363 | 4,404 |
Unrealized Loss | ||
Less than 12 months, unrealized loss | 6 | 459 |
More than 12 months, unrealized loss | 498 | 0 |
Unrealized loss | 504 | 459 |
U.S. government obligations | ||
Fair Value | ||
Less than 12 months, fair value | 0 | 18,764 |
More than 12 months, fair value | 32,333 | 13,041 |
Fair value | 32,333 | 31,805 |
Unrealized Loss | ||
Less than 12 months, unrealized loss | 0 | 1,137 |
More than 12 months, unrealized loss | 2,535 | 1,910 |
Unrealized loss | $ 2,535 | $ 3,047 |
Investment Securities (Maturiti
Investment Securities (Maturities Schedule) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Amortized Cost | ||
Within one year | $ 37,444 | $ 35,441 |
Over one year through five years | 132,267 | 136,449 |
Over five years through ten years | 224,597 | 228,997 |
After ten years | 119,974 | 120,138 |
Amortized Cost | 514,282 | 521,025 |
Estimated Fair Value | ||
Within one year | 33,780 | 31,477 |
Over one year through five years | 119,322 | 121,186 |
Over five years through ten years | 202,615 | 203,383 |
After ten years | 108,232 | 106,700 |
Securities available for sale ("AFS"), at fair value | $ 463,949 | $ 462,746 |
Loans (Schedule of Accounts, No
Loans (Schedule of Accounts, Notes, Loans and Financing Receivable) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2022 | Dec. 31, 2021 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | $ 1,844,321 | $ 1,821,407 | ||
Less | ||||
Less: Allowance for Credit Losses | (23,515) | (22,890) | $ (21,382) | $ (18,417) |
Total net portfolio loans | 1,820,806 | 1,798,517 | ||
Accrued interest receivable | 8,526 | 8,335 | ||
Portfolio Loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | 1,844,321 | 1,821,407 | ||
Less | ||||
Less: Allowance for Credit Losses | $ (23,515) | $ (22,890) | ||
Allowance for loan losses, percentage | (1.27%) | (1.26%) | ||
Total net portfolio loans | $ 1,820,806 | $ 1,798,178 | ||
Portfolio Loans, Excluding US SBA PPP Loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | $ 1,844,321 | $ 1,821,068 | ||
Percentage status of loan in portfolio | 100% | 100% | ||
Commercial Real Estate | ||||
Less | ||||
Less: Allowance for Credit Losses | $ (18,392) | $ (17,650) | (17,313) | (13,095) |
Commercial Real Estate | Portfolio Loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | $ 1,265,519 | $ 1,232,826 | ||
Percentage status of loan in portfolio | 68.63% | 67.69% | ||
Residential First Mortgages | ||||
Less | ||||
Less: Allowance for Credit Losses | $ (203) | $ (207) | (284) | (1,002) |
Residential First Mortgages | Portfolio Loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | $ 78,186 | $ 79,872 | ||
Percentage status of loan in portfolio | 4.24% | 4.39% | ||
Residential Rentals | ||||
Less | ||||
Less: Allowance for Credit Losses | $ (2,905) | $ (3,061) | (1,546) | (2,175) |
Residential Rentals | Portfolio Loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | $ 329,417 | $ 338,292 | ||
Percentage status of loan in portfolio | 17.86% | 18.58% | ||
Construction and Land Development | ||||
Less | ||||
Less: Allowance for Credit Losses | $ (161) | $ (160) | (137) | (260) |
Construction and Land Development | Portfolio Loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | $ 18,474 | $ 17,259 | ||
Percentage status of loan in portfolio | 1% | 0.95% | ||
Home equity and second mortgages | Portfolio Loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | $ 25,492 | $ 25,602 | ||
Percentage status of loan in portfolio | 1.38% | 1.41% | ||
Commercial Loans | ||||
Less | ||||
Less: Allowance for Credit Losses | $ (204) | $ (190) | (319) | (582) |
Commercial Loans | Portfolio Loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | $ 40,666 | $ 42,055 | ||
Percentage status of loan in portfolio | 2.20% | 2.31% | ||
Consumer Loans | ||||
Less | ||||
Less: Allowance for Credit Losses | $ (166) | $ (154) | (73) | (58) |
Consumer Loans | Portfolio Loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | $ 7,271 | $ 6,272 | ||
Percentage status of loan in portfolio | 0.39% | 0.34% | ||
Commercial Equipment | ||||
Less | ||||
Less: Allowance for Credit Losses | $ (1,353) | $ (1,342) | $ (1,532) | $ (971) |
Commercial Equipment | Portfolio Loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | $ 79,296 | $ 78,890 | ||
Percentage status of loan in portfolio | 4.30% | 4.33% | ||
U.S. SBA PPP | Non Portfolio Loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross loans | $ 339 | |||
Less | ||||
Total net portfolio loans | $ 0 | 339 | ||
Accrued interest receivable | $ 6,800 | $ 6,600 |
Loans (Narrative) (Details)
Loans (Narrative) (Details) | 3 Months Ended | 12 Months Ended | |||||
Mar. 31, 2023 USD ($) loan tDR_Loan | Dec. 31, 2022 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2022 USD ($) loan | Dec. 31, 2022 USD ($) tDR_Loan | Dec. 31, 2022 USD ($) Loan | Dec. 31, 2020 USD ($) | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Deferred loan fee and premiums, net | $ (3,900,000) | $ 3,000,000 | |||||
Deferred loan fees and premiums include net deferred fees paid by customers | 8,300,000 | 7,300,000 | $ 7,300,000 | $ 7,300,000 | $ 7,300,000 | $ 7,300,000 | |
Total deferred fee and premiums | 4,400,000 | 4,300,000 | 4,300,000 | 4,300,000 | 4,300,000 | 4,300,000 | |
Gross loans | $ 1,844,321,000 | 1,821,407,000 | 1,821,407,000 | 1,821,407,000 | 1,821,407,000 | 1,821,407,000 | |
Service rights retained, percent of outstanding balance | 0.25% | ||||||
Service rights retained, amount | $ 19,100,000 | 19,500,000 | 19,500,000 | 19,500,000 | 19,500,000 | 19,500,000 | |
Non-accrual Delinquent Loans | 727,000 | 655,000 | 655,000 | 655,000 | 655,000 | 655,000 | |
Nonaccrual | $ 8,124,000 | 6,115,000 | $ 6,115,000 | $ 6,115,000 | $ 6,115,000 | $ 6,115,000 | |
Number of BEFDs loans modified in the period | loan | 0 | 0 | |||||
Total BEFDs modifications | 1 | 2 | 1 | ||||
Reserve amount | $ 27,000 | 28,000 | |||||
Financing receivable, excluding accrued interest, modified in period, amount | 0 | ||||||
Reserve for number of contracts | Loan | 1 | ||||||
Number of contracts for disposal | Loan | 0 | ||||||
Principal curtailment | $ 1,000 | $ 18,000 | |||||
Loan Delinquency | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Percentage status of loan in portfolio | 0.08% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | |
Nonaccrual | $ 1,500,000 | $ 1,000,000 | $ 1,000,000 | $ 1,000,000 | $ 1,000,000 | $ 1,000,000 | |
Increase (decrease) In loan delinquency | $ 400,000 | ||||||
Nonaccrual Loans | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Percentage status of loan in portfolio | 0.44% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | |
Increase (decrease) in finance receivables | $ 2,000,000 | ||||||
Non-accrual Delinquent Loans | $ 8,100,000 | 6,100,000 | $ 6,100,000 | $ 6,100,000 | $ 6,100,000 | $ 6,100,000 | |
Nonaccrual Loans With No Impairment | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Nonaccrual | 6,700,000 | 6,000,000 | $ 6,000,000 | 6,000,000 | 6,000,000 | 6,000,000 | |
Percentage of current loans on total non accrual loans | 89% | ||||||
Interest due to debt | 43,000 | 22,000 | |||||
Nonaccrual Loans With No Impairment | Total Past Due | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Nonaccrual | 5,500,000 | $ 5,500,000 | 5,500,000 | 5,500,000 | 5,500,000 | ||
Nonaccrual Loans With Impairment | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Nonaccrual | 1,400,000 | 100,000 | $ 100,000 | 100,000 | 100,000 | 100,000 | |
Payment for principal | 100,000 | ||||||
Payment for interest | 700,000 | ||||||
Percentage of delinquent loans on total non accrual loans | 11% | ||||||
Interest due to debt | 5,000 | 1,000 | |||||
Commercial Real Estate | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Non-accrual Delinquent Loans | 0 | 0 | $ 0 | 0 | 0 | 0 | |
Nonaccrual | $ 5,889,000 | $ 4,602,000 | $ 4,602,000 | $ 4,602,000 | $ 4,602,000 | $ 4,602,000 | |
Commercial Real Estate | Minimum | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Debt maturity period (in years) | 3 years | ||||||
Commercial Real Estate | Maximum | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Debt maturity period (in years) | 20 years | ||||||
Commercial Real Estate | Commercial Construction Loans | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Percentage status of loan in portfolio | 6.20% | 6.90% | 6.90% | 6.90% | 6.90% | 6.90% | |
Percent of appraised value or sales price | 80% | ||||||
Residential First Mortgages | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Non-accrual Delinquent Loans | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||
Nonaccrual | 0 | 0 | 0 | 0 | 0 | ||
Residential First Mortgages | Minimum | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Debt maturity period (in years) | 10 years | ||||||
Residential First Mortgages | Maximum | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Debt maturity period (in years) | 30 years | ||||||
Residential Rentals | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Non-accrual Delinquent Loans | $ 274,000 | 449,000 | 449,000 | 449,000 | 449,000 | 449,000 | |
Nonaccrual | $ 1,631,000 | 1,142,000 | 1,142,000 | 1,142,000 | 1,142,000 | 1,142,000 | |
Residential Rentals | Minimum | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Debt maturity period (in years) | 3 years | ||||||
Residential Rentals | Maximum | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Debt maturity period (in years) | 20 years | ||||||
U.S. SBA PPP | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Unamortized loan commitment and origination fees and unamortized discounts or premiums | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | ||
Deferred loan fees and premiums included in deferred fees paid by SBA | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | ||
Offset by net deferred premiums paid to purchase loans | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||
Adjustable Rate Residential First Mortgage | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Gross loans | $ 1,800,000,000 | $ 1,820,000,000 | $ 1,820,000,000 | $ 1,820,000,000 | $ 1,820,000,000 | $ 1,820,000,000 | |
Adjustable Rate Residential First Mortgage | Commercial Real Estate | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Percentage status of loan in portfolio | 49.60% | 50.40% | 50.40% | 50.40% | 50.40% | 50.40% | |
Gross loans | $ 914,800,000 | $ 918,400,000 | $ 918,400,000 | $ 918,400,000 | $ 918,400,000 | $ 918,400,000 | |
Adjustable Rate Residential First Mortgage | Residential First Mortgages | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Percentage status of loan in portfolio | 0.70% | 0.70% | 0.70% | 0.70% | 0.70% | 0.70% | |
Gross loans | $ 12,900,000 | $ 13,100,000 | $ 13,100,000 | $ 13,100,000 | $ 13,100,000 | $ 13,100,000 | |
Commercial loans | Minimum | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Bank exposure, threshold limit for credit rating (or greater) | $ 1,000,000 | ||||||
Commercial loans | Maximum | |||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||
Debt maturity period (in years) | 5 years |
Loans (Schedule of Financing Re
Loans (Schedule of Financing Receivables, Non-Accrual Status) (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | $ 6,697 | $ 6,006 |
Nonaccrual with Allowance for Credit Losses | 1,427 | 109 |
Total Non-accrual Loans | 8,124 | 6,115 |
Interest Income on Nonaccrual Loans | 63 | 121 |
Interest Income on Nonaccrual Loans | 0 | 0 |
Non-accrual Delinquent Loans | 727 | 655 |
Non-accrual Current Loans | 7,397 | 5,460 |
Commercial Real Estate | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 4,498 | 4,521 |
Nonaccrual with Allowance for Credit Losses | 1,391 | 81 |
Total Non-accrual Loans | 5,889 | 4,602 |
Non-accrual Delinquent Loans | 0 | 0 |
Non-accrual Current Loans | 5,889 | 4,602 |
Residential First Mortgages | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Non-accrual Loans | 0 | |
Non-accrual Delinquent Loans | 0 | |
Non-accrual Current Loans | 0 | |
Residential Rentals | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 1,631 | 1,142 |
Nonaccrual with Allowance for Credit Losses | 0 | 0 |
Total Non-accrual Loans | 1,631 | 1,142 |
Non-accrual Delinquent Loans | 274 | 449 |
Non-accrual Current Loans | 1,357 | 693 |
Home Equity and Second Mortgages | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 444 | 206 |
Nonaccrual with Allowance for Credit Losses | 0 | 0 |
Total Non-accrual Loans | 444 | 206 |
Non-accrual Delinquent Loans | 444 | 206 |
Non-accrual Current Loans | 0 | 0 |
Consumer Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 0 | 0 |
Nonaccrual with Allowance for Credit Losses | 9 | |
Total Non-accrual Loans | 9 | |
Non-accrual Delinquent Loans | 9 | |
Non-accrual Current Loans | 0 | |
Commercial Equipment | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 124 | 137 |
Nonaccrual with Allowance for Credit Losses | 27 | 28 |
Total Non-accrual Loans | 151 | 165 |
Non-accrual Delinquent Loans | 0 | 0 |
Non-accrual Current Loans | $ 151 | 165 |
U.S. SBA PPP | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Non-accrual Loans | 0 | |
Non-accrual Delinquent Loans | 0 | |
Non-accrual Current Loans | $ 0 |
Loans (Past Due Financing Recei
Loans (Past Due Financing Receivables) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | $ 1,844,321 | $ 1,821,407 |
Nonaccrual | 8,124 | 6,115 |
Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 1,844,321 | 1,821,407 |
Purchased credit impaired | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 7,397 | 5,460 |
Current Accrual Loans | All Other Loans | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 1,835,456 | 1,814,905 |
Total Past Due | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 1,468 | 1,042 |
31-60 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 854 | 232 |
61-89 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 100 | 372 |
90 DPD Still Accruing and Not Accruing | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 35 | 50 |
Nonaccrual | 479 | 388 |
Commercial Real Estate | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 5,889 | 4,602 |
Commercial Real Estate | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 1,265,519 | 1,232,826 |
Commercial Real Estate | Purchased credit impaired | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 5,889 | 4,602 |
Commercial Real Estate | Current Accrual Loans | All Other Loans | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 1,259,105 | 1,228,077 |
Commercial Real Estate | Total Past Due | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 525 | 147 |
Commercial Real Estate | 31-60 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 525 | 147 |
Commercial Real Estate | 61-89 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Commercial Real Estate | 90 DPD Still Accruing and Not Accruing | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Nonaccrual | 0 | 0 |
Residential First Mortgages | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 0 | |
Residential First Mortgages | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 78,186 | 79,872 |
Residential First Mortgages | Purchased credit impaired | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 0 | 0 |
Residential First Mortgages | Current Accrual Loans | All Other Loans | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 78,186 | 79,872 |
Residential First Mortgages | Total Past Due | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Residential First Mortgages | 31-60 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Residential First Mortgages | 61-89 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Residential First Mortgages | 90 DPD Still Accruing and Not Accruing | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Nonaccrual | 0 | 0 |
Residential Rentals | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 1,631 | 1,142 |
Residential Rentals | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 329,417 | 338,292 |
Residential Rentals | Purchased credit impaired | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 1,357 | 693 |
Residential Rentals | Current Accrual Loans | All Other Loans | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 327,786 | 337,150 |
Residential Rentals | Total Past Due | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 274 | 449 |
Residential Rentals | 31-60 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Residential Rentals | 61-89 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 177 |
Residential Rentals | 90 DPD Still Accruing and Not Accruing | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Nonaccrual | 274 | 272 |
Construction and Land Development | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 18,474 | 17,259 |
Construction and Land Development | Purchased credit impaired | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 0 | 0 |
Construction and Land Development | Current Accrual Loans | All Other Loans | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 18,474 | 17,259 |
Construction and Land Development | Total Past Due | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Construction and Land Development | 31-60 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Construction and Land Development | 61-89 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Construction and Land Development | 90 DPD Still Accruing and Not Accruing | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Nonaccrual | 0 | 0 |
Home equity and second mortgages | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 25,492 | 25,602 |
Home equity and second mortgages | Purchased credit impaired | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 0 | 0 |
Home equity and second mortgages | Current Accrual Loans | All Other Loans | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 24,954 | 25,273 |
Home equity and second mortgages | Total Past Due | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 538 | 329 |
Home equity and second mortgages | 31-60 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 263 | 53 |
Home equity and second mortgages | 61-89 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 70 | 160 |
Home equity and second mortgages | 90 DPD Still Accruing and Not Accruing | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Nonaccrual | 205 | 116 |
Commercial Loans | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 40,666 | 42,055 |
Commercial Loans | Purchased credit impaired | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 0 | 0 |
Commercial Loans | Current Accrual Loans | All Other Loans | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 40,666 | 42,055 |
Commercial Loans | Total Past Due | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Commercial Loans | 31-60 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Commercial Loans | 61-89 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Commercial Loans | 90 DPD Still Accruing and Not Accruing | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Nonaccrual | 0 | 0 |
Consumer Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 9 | |
Consumer Loans | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 7,271 | 6,272 |
Consumer Loans | Purchased credit impaired | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 0 | 0 |
Consumer Loans | Current Accrual Loans | All Other Loans | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 7,140 | 6,166 |
Consumer Loans | Total Past Due | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 131 | 106 |
Consumer Loans | 31-60 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 66 | 21 |
Consumer Loans | 61-89 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 30 | 35 |
Consumer Loans | 90 DPD Still Accruing and Not Accruing | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 35 | 50 |
Nonaccrual | 0 | 0 |
Commercial Equipment | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 151 | 165 |
Commercial Equipment | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 79,296 | 78,890 |
Commercial Equipment | Purchased credit impaired | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 151 | 165 |
Commercial Equipment | Current Accrual Loans | All Other Loans | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 79,145 | 78,714 |
Commercial Equipment | Total Past Due | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 11 |
Commercial Equipment | 31-60 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 11 |
Commercial Equipment | 61-89 DPD | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Commercial Equipment | 90 DPD Still Accruing and Not Accruing | Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | 0 |
Nonaccrual | $ 0 | 0 |
U.S. SBA PPP | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Nonaccrual | 0 | |
U.S. SBA PPP | Non Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 339 | |
Nonaccrual | 0 | |
U.S. SBA PPP | Current Accrual Loans | Non Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 339 | |
U.S. SBA PPP | Total Past Due | Non Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | |
U.S. SBA PPP | 31-60 DPD | Non Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | |
U.S. SBA PPP | 61-89 DPD | Non Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | |
U.S. SBA PPP | 90 DPD Still Accruing and Not Accruing | Non Portfolio Loans | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Gross loans | 0 | |
Nonaccrual | $ 0 |
Loans (Allowance for Credit Los
Loans (Allowance for Credit Losses "ACL" on Financing Receivables) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | $ 22,890 | $ 18,417 |
Charge-offs | (65) | 0 |
Recoveries | 20 | 19 |
Provisions | 670 | 450 |
Ending Balance | 23,515 | 21,382 |
Cumulative Effect, Period of Adoption, Adjustment | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | 2,496 | |
Commercial Real Estate | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | 17,650 | 13,095 |
Charge-offs | 0 | 0 |
Recoveries | 16 | 0 |
Provisions | 726 | 484 |
Ending Balance | 18,392 | 17,313 |
Commercial Real Estate | Cumulative Effect, Period of Adoption, Adjustment | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | 3,734 | |
Residential First Mortgages | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | 207 | 1,002 |
Charge-offs | 0 | 0 |
Recoveries | 0 | 0 |
Provisions | (4) | (39) |
Ending Balance | 203 | 284 |
Residential First Mortgages | Cumulative Effect, Period of Adoption, Adjustment | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | (679) | |
Residential Rentals | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | 3,061 | 2,175 |
Charge-offs | 0 | 0 |
Recoveries | 0 | 0 |
Provisions | (156) | (43) |
Ending Balance | 2,905 | 1,546 |
Residential Rentals | Cumulative Effect, Period of Adoption, Adjustment | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | (586) | |
Construction and Land Development | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | 160 | 260 |
Charge-offs | 0 | 0 |
Recoveries | 0 | 0 |
Provisions | 1 | (41) |
Ending Balance | 161 | 137 |
Construction and Land Development | Cumulative Effect, Period of Adoption, Adjustment | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | (82) | |
Home Equity and Second Mortgages | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | 126 | 274 |
Charge-offs | 0 | 0 |
Recoveries | 0 | 0 |
Provisions | 5 | (10) |
Ending Balance | 131 | 178 |
Home Equity and Second Mortgages | Cumulative Effect, Period of Adoption, Adjustment | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | (86) | |
Commercial Loans | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | 190 | 582 |
Charge-offs | 0 | 0 |
Recoveries | 0 | 1 |
Provisions | 14 | 26 |
Ending Balance | 204 | 319 |
Commercial Loans | Cumulative Effect, Period of Adoption, Adjustment | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | (290) | |
Consumer Loans | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | 154 | 58 |
Charge-offs | (44) | 0 |
Recoveries | 0 | 0 |
Provisions | 56 | 13 |
Ending Balance | 166 | 73 |
Consumer Loans | Cumulative Effect, Period of Adoption, Adjustment | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | 2 | |
Commercial Equipment | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | 1,342 | 971 |
Charge-offs | (21) | 0 |
Recoveries | 4 | 18 |
Provisions | 28 | 60 |
Ending Balance | $ 1,353 | 1,532 |
Commercial Equipment | Cumulative Effect, Period of Adoption, Adjustment | ||
Loans and Leases Receivable Disclosure [Abstract] | ||
Beginning Balance | $ 483 |
Loans (Amortized Cost for Colla
Loans (Amortized Cost for Collateral-Dependent Loans by Class of Loans) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | $ 6,697 | $ 6,006 |
Commercial Real Estate | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 4,498 | 4,521 |
Residential Rentals | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 1,631 | 1,142 |
Home Equity and Second Mortgages | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 444 | 206 |
Consumer Loans | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 0 | 0 |
Commercial Equipment | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 124 | 137 |
Business/Other Assets | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 160 | 595 |
Business/Other Assets | Commercial Real Estate | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 0 | 0 |
Business/Other Assets | Residential Rentals | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 0 | 0 |
Business/Other Assets | Home Equity and Second Mortgages | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 0 | 0 |
Business/Other Assets | Consumer Loans | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 9 | |
Business/Other Assets | Commercial Equipment | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 151 | 595 |
Real Estate | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 7,964 | 5,949 |
Real Estate | Commercial Real Estate | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 5,889 | 4,601 |
Real Estate | Residential Rentals | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 1,631 | 1,142 |
Real Estate | Home Equity and Second Mortgages | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 444 | 206 |
Real Estate | Consumer Loans | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | 0 | |
Real Estate | Commercial Equipment | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Nonaccrual with No Allowance for Credit Losses | $ 0 | $ 0 |
Loans (Risk Category of Loans b
Loans (Risk Category of Loans by Class of Loans) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | |
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | $ 552,259 | $ 461,554 |
2019 | 170,712 | 104,237 |
2020 | 247,147 | 172,653 |
2021 | 366,482 | 252,529 |
2022 | 451,019 | 370,691 |
2023 | 51,265 | 455,235 |
Revolving Loans | 5,437 | 4,508 |
Total | 1,844,321 | 1,821,407 |
Total loans by risk category | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 496,881 | 409,552 |
2019 | 150,358 | 99,029 |
2020 | 237,337 | 152,105 |
2021 | 357,132 | 242,447 |
2022 | 440,875 | 360,687 |
2023 | 50,789 | 445,502 |
Revolving Loans | 0 | 0 |
Total | 1,733,372 | 1,709,322 |
Total loans evaluated by performing status | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 55,378 | 52,002 |
2019 | 20,354 | 5,208 |
2020 | 9,810 | 20,548 |
2021 | 9,350 | 10,082 |
2022 | 10,144 | 10,004 |
2023 | 476 | 9,733 |
Revolving Loans | 5,437 | 4,508 |
Total | 110,949 | 112,085 |
Commercial Real Estate | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Current period gross write-off, prior | 0 | |
Current period gross write-off, 2019 | 0 | |
Current period gross write-off, 2020 | 0 | |
Current period gross write-off, 2021 | 0 | |
Current period gross write-off, 2022 | 0 | |
Current period gross write-off, 2023 | 0 | |
Current period gross write-off, revolving loans | 0 | |
Current period gross write-off, total | 0 | |
Commercial Real Estate | Pass | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 393,557 | 329,575 |
2019 | 108,531 | 73,742 |
2020 | 175,180 | 107,264 |
2021 | 261,755 | 184,263 |
2022 | 287,060 | 272,567 |
2023 | 23,827 | 256,622 |
Revolving Loans | 0 | 0 |
Total | 1,249,910 | 1,224,033 |
Commercial Real Estate | Special Mention | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 4,167 | 0 |
2019 | 0 | 4,191 |
2020 | 5,553 | 0 |
2021 | 0 | 0 |
2022 | 0 | 0 |
2023 | 0 | 0 |
Revolving Loans | 0 | 0 |
Total | 9,720 | 4,191 |
Commercial Real Estate | Substandard | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 2,088 | 792 |
2019 | 2,960 | 0 |
2020 | 0 | 2,967 |
2021 | 841 | 0 |
2022 | 0 | 843 |
2023 | 0 | 0 |
Revolving Loans | 0 | 0 |
Total | 5,889 | 4,602 |
Commercial Real Estate | Total loans by risk category | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 399,812 | 330,367 |
2019 | 111,491 | 77,933 |
2020 | 180,733 | 110,231 |
2021 | 262,596 | 184,263 |
2022 | 287,060 | 273,410 |
2023 | 23,827 | 256,622 |
Revolving Loans | 0 | 0 |
Total | 1,265,519 | 1,232,826 |
Residential Rentals | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Current period gross write-off, prior | 0 | |
Current period gross write-off, 2019 | 0 | |
Current period gross write-off, 2020 | 0 | |
Current period gross write-off, 2021 | 0 | |
Current period gross write-off, 2022 | 0 | |
Current period gross write-off, 2023 | 0 | |
Current period gross write-off, revolving loans | 0 | |
Current period gross write-off, total | 0 | |
Residential Rentals | Pass | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 46,757 | 44,257 |
2019 | 20,527 | 4,429 |
2020 | 47,452 | 20,690 |
2021 | 72,733 | 48,237 |
2022 | 119,293 | 65,889 |
2023 | 21,024 | 153,648 |
Revolving Loans | 0 | 0 |
Total | 327,786 | 337,150 |
Residential Rentals | Special Mention | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 0 | 0 |
2019 | 0 | 0 |
2020 | 0 | 0 |
2021 | 0 | 0 |
2022 | 0 | 0 |
2023 | 0 | 0 |
Revolving Loans | 0 | 0 |
Total | 0 | 0 |
Residential Rentals | Substandard | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 1,631 | 1,142 |
2019 | 0 | 0 |
2020 | 0 | 0 |
2021 | 0 | 0 |
2022 | 0 | 0 |
2023 | 0 | 0 |
Revolving Loans | 0 | 0 |
Total | 1,631 | 1,142 |
Residential Rentals | Total loans by risk category | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 48,388 | 45,399 |
2019 | 20,527 | 4,429 |
2020 | 47,452 | 20,690 |
2021 | 72,733 | 48,237 |
2022 | 119,293 | 65,889 |
2023 | 21,024 | 153,648 |
Revolving Loans | 0 | 0 |
Total | 329,417 | 338,292 |
Construction and Land Development | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Current period gross write-off, prior | 0 | |
Current period gross write-off, 2019 | 0 | |
Current period gross write-off, 2020 | 0 | |
Current period gross write-off, 2021 | 0 | |
Current period gross write-off, 2022 | 0 | |
Current period gross write-off, 2023 | 0 | |
Current period gross write-off, revolving loans | 0 | |
Current period gross write-off, total | 0 | |
Construction and Land Development | Pass | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 11,181 | 2,355 |
2019 | 2,595 | 7,788 |
2020 | 631 | 4,255 |
2021 | 3,360 | 729 |
2022 | 148 | 2,020 |
2023 | 559 | 112 |
Revolving Loans | 0 | 0 |
Total | 18,474 | 17,259 |
Construction and Land Development | Special Mention | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 0 | 0 |
2019 | 0 | 0 |
2020 | 0 | 0 |
2021 | 0 | 0 |
2022 | 0 | 0 |
2023 | 0 | 0 |
Revolving Loans | 0 | 0 |
Total | 0 | 0 |
Construction and Land Development | Substandard | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 0 | 0 |
2019 | 0 | 0 |
2020 | 0 | 0 |
2021 | 0 | 0 |
2022 | 0 | 0 |
2023 | 0 | 0 |
Revolving Loans | 0 | 0 |
Total | 0 | 0 |
Construction and Land Development | Total loans by risk category | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 11,181 | 2,355 |
2019 | 2,595 | 7,788 |
2020 | 631 | 4,255 |
2021 | 3,360 | 729 |
2022 | 148 | 2,020 |
2023 | 559 | 112 |
Revolving Loans | 0 | 0 |
Total | 18,474 | 17,259 |
Commercial Loans | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Current period gross write-off, prior | 0 | |
Current period gross write-off, 2019 | 0 | |
Current period gross write-off, 2020 | 0 | |
Current period gross write-off, 2021 | 0 | |
Current period gross write-off, 2022 | 0 | |
Current period gross write-off, 2023 | 0 | |
Current period gross write-off, revolving loans | 0 | |
Current period gross write-off, total | 0 | |
Commercial Loans | Pass | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 25,502 | 23,225 |
2019 | 2,260 | 4,298 |
2020 | 1,985 | 2,463 |
2021 | 6,258 | 1,872 |
2022 | 3,708 | 6,420 |
2023 | 953 | 3,777 |
Revolving Loans | 0 | 0 |
Total | 40,666 | 42,055 |
Commercial Loans | Special Mention | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 0 | 0 |
2019 | 0 | 0 |
2020 | 0 | 0 |
2021 | 0 | 0 |
2022 | 0 | 0 |
2023 | 0 | 0 |
Revolving Loans | 0 | 0 |
Total | 0 | 0 |
Commercial Loans | Substandard | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 0 | 0 |
2019 | 0 | 0 |
2020 | 0 | 0 |
2021 | 0 | 0 |
2022 | 0 | 0 |
2023 | 0 | 0 |
Revolving Loans | 0 | 0 |
Total | 0 | 0 |
Commercial Loans | Total loans by risk category | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 25,502 | 23,225 |
2019 | 2,260 | 4,298 |
2020 | 1,985 | 2,463 |
2021 | 6,258 | 1,872 |
2022 | 3,708 | 6,420 |
2023 | 953 | 3,777 |
Revolving Loans | 0 | 0 |
Total | 40,666 | 42,055 |
Commercial Equipment | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Current period gross write-off, prior | (21) | |
Current period gross write-off, 2019 | 0 | |
Current period gross write-off, 2020 | 0 | |
Current period gross write-off, 2021 | 0 | |
Current period gross write-off, 2022 | 0 | |
Current period gross write-off, 2023 | 0 | |
Current period gross write-off, revolving loans | 0 | |
Current period gross write-off, total | (21) | |
Commercial Equipment | Pass | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 11,833 | 8,206 |
2019 | 13,361 | 4,411 |
2020 | 6,536 | 14,329 |
2021 | 12,185 | 7,346 |
2022 | 30,638 | 12,948 |
2023 | 4,426 | 31,315 |
Revolving Loans | 0 | 0 |
Total | 78,979 | 78,555 |
Commercial Equipment | Special Mention | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 165 | 0 |
2019 | 0 | 170 |
2020 | 0 | 0 |
2021 | 0 | 0 |
2022 | 0 | 0 |
2023 | 0 | 0 |
Revolving Loans | 0 | 0 |
Total | 165 | 170 |
Commercial Equipment | Substandard | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 0 | 0 |
2019 | 124 | 0 |
2020 | 0 | 137 |
2021 | 0 | 0 |
2022 | 28 | 0 |
2023 | 0 | 28 |
Revolving Loans | 0 | 0 |
Total | 152 | 165 |
Commercial Equipment | Total loans by risk category | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 11,998 | 8,206 |
2019 | 13,485 | 4,581 |
2020 | 6,536 | 14,466 |
2021 | 12,185 | 7,346 |
2022 | 30,666 | 12,948 |
2023 | 4,426 | 31,343 |
Revolving Loans | 0 | 0 |
Total | 79,296 | 78,890 |
Residential First Mortgages | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Current period gross write-off, prior | 0 | |
Current period gross write-off, 2019 | 0 | |
Current period gross write-off, 2020 | 0 | |
Current period gross write-off, 2021 | 0 | |
Current period gross write-off, 2022 | 0 | |
Current period gross write-off, 2023 | 0 | |
Current period gross write-off, revolving loans | 0 | |
Current period gross write-off, total | 0 | |
Residential First Mortgages | Performing | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 39,629 | 37,428 |
2019 | 19,273 | 3,584 |
2020 | 8,465 | 19,411 |
2021 | 5,178 | 8,523 |
2022 | 5,641 | 5,235 |
2023 | 0 | 5,691 |
Revolving Loans | 0 | 0 |
Total | 78,186 | 79,872 |
Residential First Mortgages | Non-performing | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 0 | 0 |
2019 | 0 | 0 |
2020 | 0 | 0 |
2021 | 0 | 0 |
2022 | 0 | 0 |
2023 | 0 | 0 |
Revolving Loans | 0 | 0 |
Total | 0 | 0 |
Residential First Mortgages | Total loans evaluated by performing status | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 39,629 | 37,428 |
2019 | 19,273 | 3,584 |
2020 | 8,465 | 19,411 |
2021 | 5,178 | 8,523 |
2022 | 5,641 | 5,235 |
2023 | 0 | 5,691 |
Revolving Loans | 0 | 0 |
Total | 78,186 | 79,872 |
Home equity and second mortgages | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Current period gross write-off, prior | 0 | |
Current period gross write-off, 2019 | 0 | |
Current period gross write-off, 2020 | 0 | |
Current period gross write-off, 2021 | 0 | |
Current period gross write-off, 2022 | 0 | |
Current period gross write-off, 2023 | 0 | |
Current period gross write-off, revolving loans | 0 | |
Current period gross write-off, total | 0 | |
Home equity and second mortgages | Performing | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 15,259 | |
2019 | 1,012 | |
2020 | 1,244 | |
2021 | 3,599 | |
2022 | 3,729 | |
2023 | 205 | |
Revolving Loans | 0 | |
Total | 25,048 | |
Home equity and second mortgages | Non-performing | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 444 | |
2019 | 0 | |
2020 | 0 | |
2021 | 0 | |
2022 | 0 | |
2023 | 0 | |
Revolving Loans | 0 | |
Total | 444 | |
Home equity and second mortgages | Total loans evaluated by performing status | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 15,703 | |
2019 | 1,012 | |
2020 | 1,244 | |
2021 | 3,599 | |
2022 | 3,729 | |
2023 | 205 | |
Revolving Loans | 0 | |
Total | 25,492 | |
Consumer Loans | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Current period gross write-off, prior | 0 | |
Current period gross write-off, 2019 | 0 | |
Current period gross write-off, 2020 | 0 | |
Current period gross write-off, 2021 | 0 | |
Current period gross write-off, 2022 | 0 | |
Current period gross write-off, 2023 | 0 | |
Current period gross write-off, revolving loans | (44) | |
Current period gross write-off, total | (44) | |
Consumer Loans | Performing | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 46 | 49 |
2019 | 69 | 2 |
2020 | 101 | 96 |
2021 | 573 | 118 |
2022 | 774 | 618 |
2023 | 271 | 881 |
Revolving Loans | 5,437 | 4,508 |
Total | 7,271 | 6,272 |
Consumer Loans | Non-performing | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 0 | 0 |
2019 | 0 | |
2020 | 0 | 0 |
2021 | 0 | |
2022 | 0 | |
2023 | 0 | |
Revolving Loans | 0 | 0 |
Total | 0 | 0 |
Consumer Loans | Total loans evaluated by performing status | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 46 | 49 |
2019 | 69 | 2 |
2020 | 101 | 96 |
2021 | 573 | 118 |
2022 | 774 | 618 |
2023 | 271 | 881 |
Revolving Loans | 5,437 | 4,508 |
Total | $ 7,271 | 6,272 |
U.S. SBA PPP | Performing | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 0 | |
2019 | 0 | |
2020 | 0 | |
2021 | 0 | |
2022 | 339 | |
2023 | 0 | |
Revolving Loans | 0 | |
Total | 339 | |
U.S. SBA PPP | Non-performing | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 0 | |
2019 | 0 | |
2020 | 0 | |
2021 | 0 | |
2022 | 0 | |
2023 | 0 | |
Revolving Loans | 0 | |
Total | 0 | |
U.S. SBA PPP | Total loans evaluated by performing status | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 0 | |
2019 | 0 | |
2020 | 0 | |
2021 | 0 | |
2022 | 339 | |
2023 | 0 | |
Revolving Loans | 0 | |
Total | 339 | |
Home Equity and Second Mortgages | Performing | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 14,319 | |
2019 | 1,622 | |
2020 | 1,041 | |
2021 | 1,441 | |
2022 | 3,812 | |
2023 | 3,161 | |
Revolving Loans | 0 | |
Total | 25,396 | |
Home Equity and Second Mortgages | Non-performing | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 206 | |
2019 | 0 | |
2020 | 0 | |
2021 | 0 | |
2022 | 0 | |
2023 | 0 | |
Revolving Loans | 0 | |
Total | 206 | |
Home Equity and Second Mortgages | Total loans evaluated by performing status | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Prior | 14,525 | |
2019 | 1,622 | |
2020 | 1,041 | |
2021 | 1,441 | |
2022 | 3,812 | |
2023 | 3,161 | |
Revolving Loans | 0 | |
Total | $ 25,602 |
Loans (Troubled Debt Restructur
Loans (Troubled Debt Restructurings on Financing Receivables) (Details) $ in Thousands | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2023 USD ($) tDR_Loan | Dec. 31, 2022 USD ($) tDR_Loan | Dec. 31, 2022 USD ($) Loan tDR_Loan | |
Number of Loans | |||
Total BEFDs modifications | 1 | 2 | 1 |
Less: BEFD modifications included in non-accrual loans | tDR_Loan | 1 | 1 | 1 |
Total accrual BEFD modifications loans | tDR_Loan | 0 | 1 | 1 |
Recorded Investments | |||
Total BEFDs modifications | $ 27 | $ 457 | $ 457 |
Less: BEFD modifications included in non-accrual loans | 27 | 28 | 28 |
Total accrual BEFD modifications loans | $ 0 | $ 429 | 429 |
Commercial Equipment | |||
Number of Loans | |||
Total BEFDs modifications | tDR_Loan | 1 | 2 | |
Recorded Investments | |||
Total BEFDs modifications | $ 27 | $ 457 | $ 457 |
Goodwill And Other Intangible_3
Goodwill And Other Intangible Assets (Goodwill) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Goodwill | $ 10,835 | $ 10,835 |
Goodwill And Other Intangible_4
Goodwill And Other Intangible Assets (Acquired intangible assets subject to amortization) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Net Intangible Assets | $ 550 | |
Core deposit intangible ("CDI") | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 3,590 | $ 3,590 |
Accumulated Amortization | (3,040) | (2,956) |
Net Intangible Assets | $ 550 | $ 634 |
Goodwill and Other Intangible_5
Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details) $ in Thousands | Mar. 31, 2023 USD ($) |
Estimated amortization expense | |
Remainder of 2023 | $ 217 |
2024 | 205 |
2025 | 109 |
2026 | 19 |
2027 | 0 |
Net Intangible Assets | $ 550 |
Goodwill and Other Intangible_6
Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Goodwill | $ 10,835,000 | $ 10,835,000 |
Goodwill, percent of equity | 5.45% | |
Goodwill and core deposit intangibles | $ 0 | $ 0 |
Core deposit intangible ("CDI") | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Core deposit intangibles | $ 600,000 | |
Core deposit intangibles, percent of equity | 0.28% |
Other Real Estate Owned ("ORE_2
Other Real Estate Owned ("OREO") (Narrative) (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Debt and Equity Securities, FV-NI [Line Items] | ||
Other real estate owned | $ 0 | $ 0 |
Operating expenses | 0 | 0 |
Residential Lots | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Impaired loans secured by residential real estate | $ 89 | $ 0 |
Deposits (Schedule Of Deposits)
Deposits (Schedule Of Deposits) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Deposits, by Type [Abstract] | ||
Non-interest-bearing deposits | $ 599,763 | $ 630,120 |
Noninterest bearing deposit liabilities, percent | 27.84% | 30.17% |
Interest-bearing deposit, Amount | ||
Demand | $ 697,312 | $ 638,876 |
Money market deposits | 305,329 | 347,872 |
Savings | 121,007 | 124,533 |
Certificates of deposit | 430,912 | 347,062 |
Total interest-bearing | 1,554,560 | 1,458,343 |
Total deposits | $ 2,154,323 | $ 2,088,463 |
Interest-bearing deposit, percent | ||
Demand | 32.37% | 30.59% |
Money market deposits | 14.17% | 16.66% |
Savings | 5.62% | 5.96% |
Certificates of deposit | 20% | 16.62% |
Total interest-bearing | 72.16% | 69.83% |
Total Deposits | 100% | 100% |
Deposits (Narrative) (Details)
Deposits (Narrative) (Details) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 USD ($) customer_relationship | Dec. 31, 2022 USD ($) customer_relationship | |
Deposit Liability [Line Items] | ||
Time deposits 250000 or more | $ 193,300 | $ 114,700 |
Total deposits | $ 2,154,323 | $ 2,088,463 |
Customer Concentration Risk | Sales Revenue, Net | ||
Deposit Liability [Line Items] | ||
Concentration risk, customer with deposits exceeding threshold | customer_relationship | 2 | 2 |
Total deposits | $ 320,900 | $ 346,400 |
Concentration risk percentage of total deposits | 14.90% | 16.60% |
Customer Concentration Risk | Sales Revenue, Net | Product | ||
Deposit Liability [Line Items] | ||
Concentration risk, percentage | 2% | 2% |
Deposits (Scheduled Contractual
Deposits (Scheduled Contractual Maturities Of Certificates Of Deposit ) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Deposits, by Type [Abstract] | ||
Within one year | $ 288,627 | |
Year 2 | 87,400 | |
Year 3 | 39,196 | |
Year 4 | 4,470 | |
Year 5 | 11,219 | |
Total | $ 430,912 | $ 347,062 |
Lease Commitments & Contingen_3
Lease Commitments & Contingencies (Right of Use Assets, Net of Accumulated Amortization) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Operating Leases | ||
Operating lease right of use asset, net | $ 5,817 | $ 5,920 |
Operating lease liability | $ 6,114 | $ 6,202 |
Weighted average remaining lease term (in years) | 15 years 6 months | 15 years 8 months 12 days |
Weighted average discount rate | 3.51% | 3.51% |
Minimum | ||
Operating Leases | ||
Remaining lease term (in years) | 4 years 3 months 18 days | 4 years 6 months |
Maximum | ||
Operating Leases | ||
Remaining lease term (in years) | 21 years | 22 years |
Lease Commitments & Contingen_4
Lease Commitments & Contingencies (Lease Cost) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | ||
Operating lease cost | $ 158 | $ 146 |
Cash paid for lease liability | $ 142 | $ 131 |
Lease Commitments & Contingen_5
Lease Commitments & Contingencies (Maturity Analysis of Operating Lease Liabilities) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Commitments and Contingencies Disclosure [Abstract] | ||
Within one year | $ 578 | |
After one but within two years | 590 | |
After two but within three years | 631 | |
After three but within four years | 640 | |
After four but within five years | 589 | |
After five years | 5,095 | |
Total undiscounted cash flows | 8,123 | |
Discount on cash flows | 2,009 | |
Operating lease liability | $ 6,114 | $ 6,202 |
Guaranteed Preferred Benefici_2
Guaranteed Preferred Beneficial Interest in Junior Subordinated Debentures ("TRUPs") (Narrative) (Details) - USD ($) | 3 Months Ended | ||
Jun. 15, 2005 | Jul. 22, 2004 | Mar. 31, 2023 | |
Capital Trust I I | |||
Debt Instrument [Line Items] | |||
Debt instrument, face amount | $ 5,000,000 | ||
Basis spread on variable rate (as a percent) | 1.70% | ||
Additional amount contributed to purchase debt | 200,000 | ||
Junior subordinated notes purchased | $ 5,200,000 | ||
Capital Trust I | |||
Debt Instrument [Line Items] | |||
Debt instrument, face amount | $ 7,000,000 | ||
Basis spread on variable rate (as a percent) | 2.60% | ||
Additional amount contributed to purchase debt | $ 200,000 | ||
Junior subordinated notes purchased | $ 7,200,000 |
Subordinated Notes (Details)
Subordinated Notes (Details) - USD ($) $ in Thousands | Oct. 14, 2020 | Mar. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2022 |
Debt Instrument [Line Items] | ||||
Subordinated notes | $ 19,580 | $ 19,566 | ||
Fixed 4.75% to Floating Rate Notes, Due 2030 | ||||
Debt Instrument [Line Items] | ||||
Subordinated notes | $ 20,000 | |||
Stated interest rate (as a percentage) | 4.75% | |||
Fixed 4.75% to Floating Rate Notes, Due 2030 | Minimum | ||||
Debt Instrument [Line Items] | ||||
Debt issuance costs | $ 600 | $ 14 | $ 14 | |
Fixed 4.75% to Floating Rate Notes, Due 2030 | Federal Home Loan Bank of New York | ||||
Debt Instrument [Line Items] | ||||
Basis spread on variable rate (as a percent) | 4.58% |
Regulatory Capital (Narrative)
Regulatory Capital (Narrative) (Details) - Minimum | Mar. 31, 2023 |
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items] | |
Common equity Tier 1 capital to risk-weighted assets minimum ratio | 4.50% |
Minimum ratio of Tier 1 capital to risk-weighted assets | 0.060 |
Total Capital to risk-weighted assets | 0.080 |
Tier 1 leverage ratio | 0.040 |
Regulatory Capital (Schedule of
Regulatory Capital (Schedule of Regulatory Capital Amounts and Ratios) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Regulatory Assets | ||
Common equity | $ 198,806 | $ 187,011 |
Goodwill | (10,835) | (10,835) |
Core deposit intangible (net of deferred tax liability) | (414) | (477) |
AOCI losses | 37,896 | 43,092 |
Common Equity Tier 1 Capital | 225,453 | 218,791 |
TRUPs | 12,000 | 12,000 |
Tier 1 Capital | 237,453 | 230,791 |
Allowable reserve for credit losses and other Tier 2 adjustments | 23,911 | 23,303 |
Subordinated notes | 19,580 | 19,566 |
Tier 2 Capital | 280,944 | 273,660 |
Risk-Weighted Assets ("RWA") | 1,956,402 | 1,943,516 |
Average Assets ("AA") | $ 2,453,436 | $ 2,404,643 |
Common Tier 1 Capital to RWA, Regulatory Min. Ratio + CCB | 7% | |
Tier 1 Capital to RWA, Regulatory Min. Ratio + CCB | 8.50% | |
Tier 2 Capital to RWA, Regulatory Min. Ratio + CCB | 10.50% | |
Common Tier 1 Capital to RWA | 11.52% | 11.26% |
Tier 1 Capital to RWA | 0.1214 | 0.1187 |
Tier 2 Capital to RWA | 14.36% | 14.08% |
Tier 1 Capital to AA (Leverage) | 0.0968 | 0.0960 |
PCA well capitalized (as a percent) | 0.0500 | |
Bank | ||
Regulatory Assets | ||
Common equity | $ 227,967 | $ 216,408 |
Goodwill | (10,835) | (10,835) |
Core deposit intangible (net of deferred tax liability) | (414) | (477) |
AOCI losses | 37,896 | 43,092 |
Common Equity Tier 1 Capital | 254,614 | 248,188 |
Tier 1 Capital | 254,614 | 248,188 |
Allowable reserve for credit losses and other Tier 2 adjustments | 23,911 | 23,303 |
Tier 2 Capital | 278,525 | 271,491 |
Risk-Weighted Assets ("RWA") | 1,954,574 | 1,941,922 |
Average Assets ("AA") | $ 2,451,758 | $ 2,403,268 |
Common Tier 1 Capital to RWA | 13.03% | 12.78% |
Tier 1 Capital to RWA | 0.1303 | 0.1278 |
Tier 2 Capital to RWA | 14.25% | 13.98% |
Tier 1 Capital to AA (Leverage) | 0.1038 | 0.1033 |
Fair Value Measurements (Fair V
Fair Value Measurements (Fair Value, Assets Measured on Recurring Basis) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | $ 463,949 | $ 462,746 |
Equity securities carried at fair value through income | 4,380 | 4,286 |
U.S. Agency | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 12,685 | 12,356 |
Residential CMOs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 11,999 | 12,206 |
Municipal bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 82,892 | 79,618 |
Corporate bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 4,363 | 4,404 |
U.S. government obligations | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 34,317 | 33,767 |
CRA investment fund | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity securities carried at fair value through income | 4,380 | 4,286 |
Other equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity securities carried at fair value through income | 207 | 207 |
Fair Value, Measurements, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 463,949 | 462,746 |
Fair Value, Measurements, Recurring | MBS | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 114,031 | 113,670 |
Fair Value, Measurements, Recurring | CMOs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 158,728 | 159,413 |
Fair Value, Measurements, Recurring | U.S. Agency | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 12,685 | 12,356 |
Fair Value, Measurements, Recurring | Residential CMOs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 11,999 | 12,206 |
Fair Value, Measurements, Recurring | Student Loan Trust ABSs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 44,934 | 47,312 |
Fair Value, Measurements, Recurring | Municipal bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 82,892 | 79,618 |
Fair Value, Measurements, Recurring | Corporate bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 4,363 | |
Fair Value, Measurements, Recurring | U.S. government obligations | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 34,317 | 33,767 |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 1 | CRA investment fund | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity securities carried at fair value through income | 0 | 0 |
Level 1 | Other equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity securities carried at fair value through income | 0 | 0 |
Level 1 | Fair Value, Measurements, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 1 | Fair Value, Measurements, Recurring | MBS | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 1 | Fair Value, Measurements, Recurring | CMOs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 1 | Fair Value, Measurements, Recurring | U.S. Agency | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 1 | Fair Value, Measurements, Recurring | Residential CMOs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 1 | Fair Value, Measurements, Recurring | Student Loan Trust ABSs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 1 | Fair Value, Measurements, Recurring | Municipal bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 1 | Fair Value, Measurements, Recurring | Corporate bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | |
Level 1 | Fair Value, Measurements, Recurring | U.S. government obligations | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 463,949 | 462,746 |
Level 2 | CRA investment fund | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity securities carried at fair value through income | 4,380 | 4,286 |
Level 2 | Other equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity securities carried at fair value through income | 207 | 207 |
Level 2 | Fair Value, Measurements, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 463,949 | 462,746 |
Level 2 | Fair Value, Measurements, Recurring | MBS | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 114,031 | 113,670 |
Level 2 | Fair Value, Measurements, Recurring | CMOs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 158,728 | 159,413 |
Level 2 | Fair Value, Measurements, Recurring | U.S. Agency | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 12,685 | 12,356 |
Level 2 | Fair Value, Measurements, Recurring | Residential CMOs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 11,999 | 12,206 |
Level 2 | Fair Value, Measurements, Recurring | Student Loan Trust ABSs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 44,934 | 47,312 |
Level 2 | Fair Value, Measurements, Recurring | Municipal bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 82,892 | 79,618 |
Level 2 | Fair Value, Measurements, Recurring | Corporate bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 4,363 | |
Level 2 | Fair Value, Measurements, Recurring | U.S. government obligations | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 34,317 | 33,767 |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 3 | CRA investment fund | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity securities carried at fair value through income | 0 | 0 |
Level 3 | Other equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity securities carried at fair value through income | 0 | 0 |
Level 3 | Fair Value, Measurements, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 3 | Fair Value, Measurements, Recurring | MBS | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 3 | Fair Value, Measurements, Recurring | CMOs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 3 | Fair Value, Measurements, Recurring | U.S. Agency | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 3 | Fair Value, Measurements, Recurring | Residential CMOs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 3 | Fair Value, Measurements, Recurring | Student Loan Trust ABSs | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 3 | Fair Value, Measurements, Recurring | Municipal bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | 0 |
Level 3 | Fair Value, Measurements, Recurring | Corporate bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | 0 | |
Level 3 | Fair Value, Measurements, Recurring | U.S. government obligations | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Securities available for sale ("AFS"), at fair value | $ 0 | $ 0 |
Fair Value Measurements (Narrat
Fair Value Measurements (Narrative) (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
Fair Value Disclosures [Abstract] | ||
Loans with impairment, unpaid principal | $ 1.4 | $ 0.1 |
Fair Value Measurements (Fair_2
Fair Value Measurements (Fair Value, Assets and Liabilities Measured on Nonrecurring Basis) (Details) - Fair Value, Nonrecurring $ in Thousands | Mar. 31, 2023 USD ($) |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | $ 948 |
Level 1 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 0 |
Level 2 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 0 |
Level 3 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 948 |
Commercial real estate | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 948 |
Commercial real estate | Level 1 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 0 |
Commercial real estate | Level 2 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 0 |
Commercial real estate | Level 3 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 948 |
Commercial loans | Individually assessed loans with an allowances | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 0 |
Commercial loans | Level 1 | Individually assessed loans with an allowances | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 0 |
Commercial loans | Level 2 | Individually assessed loans with an allowances | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 0 |
Commercial loans | Level 3 | Individually assessed loans with an allowances | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 0 |
Commercial equipment | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 0 |
Commercial equipment | Level 1 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 0 |
Commercial equipment | Level 2 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | 0 |
Commercial equipment | Level 3 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Individually assessed loans with an allowances | $ 0 |
Fair Value Measurements (Unobse
Fair Value Measurements (Unobservable Inputs Used in Level 3 Fair Value Measurements) (Details) - Level 3 - Individually assessed loans with an allowances $ in Thousands | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Fair value disclosure of assets | $ 948 |
Minimum | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Fair value of inputs discount rate | 0% |
Maximum | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Fair value of inputs discount rate | 50% |
Weighted Average | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Fair value of inputs discount rate | 100% |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments (Fair Value, by Balance Sheet Grouping) (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Assets | ||
Estimated Fair Value | $ 463,949 | $ 462,746 |
Equity securities carried at fair value through income | 4,380 | 4,286 |
Non-marketable equity securities in other financial institutions | 207 | 207 |
FHLB Stock | 2,181 | 4,584 |
Net loans receivable | 1,759,458 | 1,743,574 |
Accrued interest receivable | 8,526 | 8,335 |
Investment in BOLI | 40,019 | 39,802 |
Liabilities | ||
Savings, NOW and money market accounts | 1,723,411 | 1,741,401 |
Time deposits | 431,741 | 346,261 |
Short-term borrowings | 21,595 | 79,087 |
TRUPs | 9,740 | 10,296 |
Subordinated notes | 18,753 | 18,745 |
Carrying Amount | ||
Assets | ||
Estimated Fair Value | 463,949 | 462,746 |
Equity securities carried at fair value through income | 4,380 | 4,286 |
Non-marketable equity securities in other financial institutions | 207 | 207 |
FHLB Stock | 2,181 | 4,584 |
Net loans receivable | 1,820,806 | 1,798,517 |
Accrued interest receivable | 8,526 | 8,335 |
Investment in BOLI | 40,019 | 39,802 |
Liabilities | ||
Savings, NOW and money market accounts | 1,723,411 | 1,741,401 |
Time deposits | 430,912 | 347,062 |
Short-term borrowings | 21,500 | 79,000 |
TRUPs | 12,000 | 12,000 |
Subordinated notes | 19,580 | 19,566 |
Level 1 | ||
Assets | ||
Estimated Fair Value | 0 | 0 |
Equity securities carried at fair value through income | 0 | 0 |
Non-marketable equity securities in other financial institutions | 0 | 0 |
FHLB Stock | 0 | 0 |
Net loans receivable | 0 | 0 |
Accrued interest receivable | 0 | 0 |
Investment in BOLI | 0 | 0 |
Liabilities | ||
Savings, NOW and money market accounts | 0 | 0 |
Time deposits | 0 | 0 |
Short-term borrowings | 0 | 0 |
TRUPs | 0 | 0 |
Subordinated notes | 0 | 0 |
Level 2 | ||
Assets | ||
Estimated Fair Value | 463,949 | 462,746 |
Equity securities carried at fair value through income | 4,380 | 4,286 |
Non-marketable equity securities in other financial institutions | 207 | 207 |
FHLB Stock | 2,181 | 4,584 |
Net loans receivable | 0 | 0 |
Accrued interest receivable | 8,526 | 8,335 |
Investment in BOLI | 40,019 | 39,802 |
Liabilities | ||
Savings, NOW and money market accounts | 1,723,411 | 1,741,401 |
Time deposits | 431,741 | 346,261 |
Short-term borrowings | 21,595 | 79,087 |
TRUPs | 9,740 | 10,296 |
Subordinated notes | 18,753 | 18,745 |
Level 3 | ||
Assets | ||
Estimated Fair Value | 0 | 0 |
Equity securities carried at fair value through income | 0 | 0 |
Non-marketable equity securities in other financial institutions | 0 | 0 |
FHLB Stock | 0 | 0 |
Net loans receivable | 1,759,458 | 1,743,574 |
Accrued interest receivable | 0 | 0 |
Investment in BOLI | 0 | 0 |
Liabilities | ||
Savings, NOW and money market accounts | 0 | 0 |
Time deposits | 0 | 0 |
Short-term borrowings | 0 | 0 |
TRUPs | 0 | 0 |
Subordinated notes | $ 0 | $ 0 |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments (Narrative) (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
Investments, All Other Investments [Abstract] | ||
Loans commitments outstanding | $ 47 | $ 44.9 |
Letters of credit outstanding, amount | 22 | 25 |
Line of credit facility, remaining borrowing capacity | $ 276.1 | $ 278.1 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income/Loss ("AOCI/"AOCL") (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Beginning Balance | $ 187,011 | $ 208,133 |
Ending Balance | 198,806 | 193,140 |
Net Unrealized Gains And Losses | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Beginning Balance | (43,092) | (1,952) |
Other comprehensive gains ( losses), net of tax before reclassifications | 5,196 | (17,017) |
Net other comprehensive gains (losses) | 5,196 | (17,017) |
Ending Balance | $ (37,896) | $ (18,969) |
Earnings Per Share ("EPS") (Nar
Earnings Per Share ("EPS") (Narrative) (Details) - shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Earnings Per Share [Abstract] | ||
Shares excluded from diluted net income per share (in shares) | 1,854 | 0 |
Earnings Per Share ("EPS") (Sch
Earnings Per Share ("EPS") (Schedule of Earnings Per Share, Basic and Diluted) (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Earnings Per Share [Abstract] | ||
Net Income | $ 7,327 | $ 6,288 |
Average number of common shares outstanding (in shares) | 5,651,750 | 5,688,221 |
Dilutive effect of common stock equivalents (in shares) | 3,832 | 10,817 |
Average number of shares used to calculate diluted EPS (in shares) | 5,655,582 | 5,699,038 |
Anti-dilutive shares (in shares) | 1,854 | 0 |
Earnings per common share, basic (in dollars per share) | $ 1.30 | $ 1.11 |
Earnings per common share, diluted (in dollars per share) | $ 1.30 | $ 1.10 |
Income Taxes (Schedule of Curre
Income Taxes (Schedule of Current and Deferred Income Tax Expense (Benefit)) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Current | ||
Current income tax expense | $ 2,375 | $ 1,927 |
Deferred | ||
Deferred income tax (benefit) expense | (7) | 206 |
Income tax expense as reported | $ 2,368 | $ 2,133 |
Effective tax rate | 24.40% | 25.30% |
Income Taxes (Narrative) (Detai
Income Taxes (Narrative) (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
Income Tax Contingency [Line Items] | |||
Net deferred tax assets | $ 21.9 | $ 24.7 | |
Valuation allowance for deferred tax assets | $ 0 | ||
Effective tax rate | 24.40% | 25.30% | |
Minimum | |||
Income Tax Contingency [Line Items] | |||
Effective tax rate | 24.50% | ||
Maximum | |||
Income Tax Contingency [Line Items] | |||
Effective tax rate | 26% |